https://timmermanreport.com/about-luke-timmerman/luketracyrogueriver/2014-12-27T06:40:08+00:00https://timmermanreport.com/wp-content/uploads/2014/12/LukeTracyRogueRiver.jpghttps://timmermanreport.com/about-luke-timmerman/p4c2013-timmerman1/2014-12-27T06:40:12+00:00https://timmermanreport.com/wp-content/uploads/2014/12/P4C2013-Timmerman1.jpghttps://timmermanreport.com/about-luke-timmerman/p4c2013-timmerman2/2014-12-27T06:40:19+00:00https://timmermanreport.com/wp-content/uploads/2014/12/P4C2013-Timmerman2.jpghttps://timmermanreport.com/about-luke-timmerman/lukeatcamp/2014-12-27T06:40:23+00:00https://timmermanreport.com/wp-content/uploads/2014/12/lukeatcamp.jpghttps://timmermanreport.com/about-luke-timmerman/rainiersummit14/2014-12-27T07:16:38+00:00https://timmermanreport.com/wp-content/uploads/2014/12/RainierSummit14-e1419664593672.jpghttps://timmermanreport.com/about-luke-timmerman/lukeandtracy/2014-12-27T07:25:28+00:00https://timmermanreport.com/wp-content/uploads/2014/12/lukeandtracy.jpghttps://timmermanreport.com/about-luke-timmerman/denalisummit/2014-12-27T07:25:59+00:00https://timmermanreport.com/wp-content/uploads/2014/12/Denalisummit.jpghttps://timmermanreport.com/about-luke-timmerman/ecuador-054-l/2014-12-27T07:26:00+00:00https://timmermanreport.com/wp-content/uploads/2014/12/ecuador-054-L-e1419665325566.jpghttps://timmermanreport.com/about-luke-timmerman/bioleschly/2014-12-27T07:30:12+00:00https://timmermanreport.com/wp-content/uploads/2014/12/BIOLeschly-e1419665405799.pnghttps://timmermanreport.com/about-luke-timmerman/denalisummitcropped/2014-12-27T07:32:42+00:00https://timmermanreport.com/wp-content/uploads/2014/12/Denalisummitcropped.jpghttps://timmermanreport.com/events/p4c2014-timmerman2/2014-12-28T06:09:42+00:00https://timmermanreport.com/wp-content/uploads/2014/12/P4C2014-Timmerman2.jpghttps://timmermanreport.com/2015/02/merck-exodus-talented-people-going/mikepowell/2015-01-28T19:18:05+00:00https://timmermanreport.com/wp-content/uploads/2015/01/mikepowell.jpghttps://timmermanreport.com/readers-saying/steverichards1/2015-01-29T05:51:17+00:00https://timmermanreport.com/wp-content/uploads/2015/01/SteveRichards1.jpghttps://timmermanreport.com/readers-saying/keolofox1/2015-01-29T19:04:30+00:00https://timmermanreport.com/wp-content/uploads/2015/01/keolofox1.jpghttps://timmermanreport.com/readers-saying/keolufox2/2015-01-29T19:05:59+00:00https://timmermanreport.com/wp-content/uploads/2015/01/keolufox2.pnghttps://timmermanreport.com/readers-saying/kleanthis-xanthopoulos-2014/2015-01-29T22:55:50+00:00https://timmermanreport.com/wp-content/uploads/2015/01/Kleanthis-Xanthopoulos-2014.jpghttps://timmermanreport.com/2015/02/welcome-timmerman-report/littletahoma/2015-02-02T04:14:28+00:00https://timmermanreport.com/wp-content/uploads/2015/01/LittleTahoma.jpghttps://timmermanreport.com/2015/02/seattle-genetics-commercial-boss-leaves-president-gig-bristol-myers/cboerner/2015-02-04T21:54:21+00:00https://timmermanreport.com/wp-content/uploads/2015/02/cboerner.jpghttps://timmermanreport.com/2015/02/former-dendreon-ceo-lures-ex-amgen-scientists-immunotherapy-startup/mgold/2015-02-06T00:51:55+00:00https://timmermanreport.com/wp-content/uploads/2015/02/mgold.jpghttps://timmermanreport.com/2015/02/qa-affymetrix-founder-stephen-fodor-resurfaces-cellular-research/fodor/2015-02-06T20:05:49+00:00https://timmermanreport.com/wp-content/uploads/2015/02/fodor.pnghttps://timmermanreport.com/2015/02/cellular-dynamics-tracks-superdonors-cell-therapy-foray/ianwilmut/2015-02-09T02:32:23+00:00https://timmermanreport.com/wp-content/uploads/2015/02/ianwilmut.pnghttps://timmermanreport.com/2015/02/faqs-timmerman-report/2014-07-13-21-05-06/2015-02-11T21:11:29+00:00https://timmermanreport.com/wp-content/uploads/2015/02/2014-07-13-21.05.06.jpghttps://timmermanreport.com/2015/02/video-alnylams-john-maraganore-canaans-julie-papanek-bio-ceo/jm/2015-02-12T21:33:13+00:00https://timmermanreport.com/wp-content/uploads/2015/02/jm.pnghttps://timmermanreport.com/2015/02/hows-going-timmerman-report-glad-asked/hans-bishop-2/2015-02-13T00:23:53+00:00https://timmermanreport.com/wp-content/uploads/2015/02/hans-bishop.jpghttps://timmermanreport.com/2015/02/hows-going-timmerman-report-glad-asked/pearlfreier-2/2015-02-13T00:24:32+00:00https://timmermanreport.com/wp-content/uploads/2015/02/pearlfreier.jpghttps://timmermanreport.com/2015/02/hows-going-timmerman-report-glad-asked/stephenfriend-2/2015-02-13T00:25:57+00:00https://timmermanreport.com/wp-content/uploads/2015/02/stephenfriend.jpghttps://timmermanreport.com/2015/02/hows-going-timmerman-report-glad-asked/carolgallagher-2/2015-02-13T00:27:53+00:00https://timmermanreport.com/wp-content/uploads/2015/02/carolgallagher.jpghttps://timmermanreport.com/2015/02/hows-going-timmerman-report-glad-asked/briangallagher-2/2015-02-13T00:30:02+00:00https://timmermanreport.com/wp-content/uploads/2015/02/briangallagher.jpghttps://timmermanreport.com/2015/02/hows-going-timmerman-report-glad-asked/staciebyars-2/2015-02-13T00:30:41+00:00https://timmermanreport.com/wp-content/uploads/2015/02/staciebyars.jpghttps://timmermanreport.com/2015/02/hows-going-timmerman-report-glad-asked/barbarayates-2/2015-02-13T05:44:34+00:00https://timmermanreport.com/wp-content/uploads/2015/02/barbarayates.jpghttps://timmermanreport.com/2015/02/hows-going-timmerman-report-glad-asked/atul-butte2\_0-2/2015-02-13T05:45:03+00:00https://timmermanreport.com/wp-content/uploads/2015/02/Atul-Butte2\_0.jpghttps://timmermanreport.com/2015/02/hows-going-timmerman-report-glad-asked/adeleneperkins-2/2015-02-13T05:46:35+00:00https://timmermanreport.com/wp-content/uploads/2015/02/adeleneperkins.jpghttps://timmermanreport.com/2015/02/hows-going-timmerman-report-glad-asked/saumitrarahatekar-2/2015-02-13T05:47:53+00:00https://timmermanreport.com/wp-content/uploads/2015/02/saumitrarahatekar.jpghttps://timmermanreport.com/2015/02/hows-going-timmerman-report-glad-asked/ethanperlstein-2/2015-02-13T05:49:38+00:00https://timmermanreport.com/wp-content/uploads/2015/02/ethanperlstein.jpghttps://timmermanreport.com/2015/02/frazier-versant-find-heart-drug-bet-laguna/james\_bio/2015-02-17T00:55:11+00:00https://timmermanreport.com/wp-content/uploads/2015/02/james\_bio.jpghttps://timmermanreport.com/2015/02/global-blood-zeroes-sickle-cell-potentially-big-touchy-opportunity/ted-love-headshot/2015-02-19T01:37:55+00:00https://timmermanreport.com/wp-content/uploads/2015/02/Ted-Love-Headshot.jpghttps://timmermanreport.com/2015/02/five-things-watch-next-weeks-big-genomics-show/dgmacarthur\_bw2/2015-02-19T23:24:00+00:00https://timmermanreport.com/wp-content/uploads/2015/02/dgmacarthur\_bw2.jpghttps://timmermanreport.com/2015/02/biotech-poised-go-public-2015-isnt/the-edge-3-2/2015-02-21T23:24:38+00:00https://timmermanreport.com/wp-content/uploads/2015/02/the-edge-31.pnghttps://timmermanreport.com/2015/03/margaret-hamburg-one-time-great-fda-commissioners/hamburg/2015-02-27T23:33:30+00:00https://timmermanreport.com/wp-content/uploads/2015/02/hamburg.pnghttps://timmermanreport.com/2015/03/come-celebrate-timmerman-report-launch-party/2013-06-10-16-54-08/2015-03-02T18:02:48+00:00https://timmermanreport.com/wp-content/uploads/2015/03/2013-06-10-16.54.08-e1425319406841.jpghttps://timmermanreport.com/2015/03/esperion-jockeys-place-statins-next-big-class-heart-drugs/esperion-bio-tim-mayleben/2015-03-06T14:01:45+00:00https://timmermanreport.com/wp-content/uploads/2015/03/esperion-bio-tim-mayleben.jpghttps://timmermanreport.com/2015/03/third-rocks-revolution-medicines-tears-apart-antifungals-atom-by-atom/mgoldsmith/2015-03-18T03:09:19+00:00https://timmermanreport.com/wp-content/uploads/2015/03/mgoldsmith.pnghttps://timmermanreport.com/2015/03/salaries-are-inching-up-in-the-biotech-boom-not-booming/radfordsurvey/2015-03-21T18:50:19+00:00https://timmermanreport.com/wp-content/uploads/2015/03/radfordsurvey.pnghttps://timmermanreport.com/2015/03/come-to-pfizer-cambridge-for-the-timmerman-report-east-coast-launch-party/califtrophy/2015-03-23T22:27:36+00:00https://timmermanreport.com/wp-content/uploads/2015/03/califtrophy-e1427149683905.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/wcoast1/2015-03-25T20:06:31+00:00https://timmermanreport.com/wp-content/uploads/2015/03/wcoast1-e1442863206759.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-104/2015-03-25T20:08:10+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-104.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-112/2015-03-25T21:28:37+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-112.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-113/2015-03-25T21:34:51+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-113.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-131/2015-03-25T21:36:40+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-131.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-135/2015-03-25T21:37:45+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-135.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-145/2015-03-25T21:38:36+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-145.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-168/2015-03-25T21:42:26+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-168.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-179/2015-03-25T21:44:04+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-179.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-201/2015-03-25T21:47:13+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-201.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-239/2015-03-25T21:48:10+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-239.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-273/2015-03-25T21:49:34+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-273.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-283/2015-03-25T21:50:26+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-283.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-333/2015-03-25T21:51:28+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-333.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-308/2015-03-25T21:53:13+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-308.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-187/2015-03-25T21:55:02+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-187.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-149/2015-03-25T21:58:50+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-149.jpghttps://timmermanreport.com/2015/03/cancer-combos-are-the-way-forward-will-drugmakers-put-patients-first/portrait-david-schenkein/2015-03-28T19:22:33+00:00https://timmermanreport.com/wp-content/uploads/2015/03/portrait-david-schenkein.jpghttps://timmermanreport.com/2015/03/cancer-combos-are-the-way-forward-will-drugmakers-put-patients-first/adeleneperkins-3/2015-03-28T19:24:17+00:00https://timmermanreport.com/wp-content/uploads/2015/03/adeleneperkins.jpghttps://timmermanreport.com/2015/04/sareptas-controversial-ceo-is-out-but-duchenne-muscular-dystrophy-rd-is-rising/img\_0206/2015-04-03T00:55:11+00:00https://timmermanreport.com/wp-content/uploads/2015/04/chamberlain1-e1428022537116.jpghttps://timmermanreport.com/2015/04/sareptas-controversial-ceo-is-out-but-duchenne-muscular-dystrophy-rd-is-rising/img\_0206-2/2015-04-03T00:57:12+00:00https://timmermanreport.com/wp-content/uploads/2015/04/chamberlain11-e1428022646618.jpghttps://timmermanreport.com/2015/04/which-big-public-investors-are-crossing-over-into-the-private-arena/pitchbook2014b/2015-04-08T19:14:47+00:00https://timmermanreport.com/wp-content/uploads/2015/04/pitchbook2014B.pnghttps://timmermanreport.com/2015/04/which-big-public-investors-are-crossing-over-into-the-private-arena/pitchbook2014c/2015-04-08T19:22:12+00:00https://timmermanreport.com/wp-content/uploads/2015/04/pitchbook2014C.pnghttps://timmermanreport.com/2015/04/which-big-public-investors-are-crossing-over-into-the-private-arena/pitchbook2014d/2015-04-08T19:23:43+00:00https://timmermanreport.com/wp-content/uploads/2015/04/pitchbook2014D.pnghttps://timmermanreport.com/2015/04/which-big-public-investors-are-crossing-over-into-the-private-arena/pitchbook2014c1/2015-04-08T19:56:25+00:00https://timmermanreport.com/wp-content/uploads/2015/04/pitchbook2014c1.pnghttps://timmermanreport.com/2015/04/the-big-boys-love-cambridge-lets-hope-they-dont-squeeze-the-life-out-of-it/mgilman\_headshot/2015-04-10T23:28:35+00:00https://timmermanreport.com/wp-content/uploads/2015/04/mgilman\_headshot.jpghttps://timmermanreport.com/2015/04/the-big-boys-love-cambridge-lets-hope-they-dont-squeeze-the-life-out-of-it/dfambrough/2015-04-10T23:37:54+00:00https://timmermanreport.com/wp-content/uploads/2015/04/dfambrough.jpghttps://timmermanreport.com/2015/04/who-should-biotech-and-pharma-industry-pros-follow-on-twitter/desouza/2015-04-14T23:26:53+00:00https://timmermanreport.com/wp-content/uploads/2015/04/desouza.jpeghttps://timmermanreport.com/2015/04/who-should-biotech-and-pharma-industry-pros-follow-on-twitter/lsuennen/2015-04-14T23:29:52+00:00https://timmermanreport.com/wp-content/uploads/2015/04/lsuennen.jpeghttps://timmermanreport.com/2015/04/aacr-conference-preview-five-themes-to-watch-in-immunotherapy/jodonnelltormey/2015-04-15T15:21:58+00:00https://timmermanreport.com/wp-content/uploads/2015/04/jodonnelltormey-e1429111352888.jpghttps://timmermanreport.com/2015/04/hungry-for-cash-academia-grabs-for-a-bigger-piece-of-biotech-action/robert\_nelsen2-2/2015-04-18T16:03:27+00:00https://timmermanreport.com/wp-content/uploads/2015/04/robert\_nelsen2.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_/2015-04-22T21:57:43+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_01.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-2/2015-04-22T21:58:27+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_04.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-3/2015-04-22T21:58:56+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_02.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-4/2015-04-22T21:59:22+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_03.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-5/2015-04-22T22:00:03+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_16.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-6/2015-04-22T22:00:32+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_15.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-7/2015-04-22T22:01:47+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_08.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-8/2015-04-22T22:02:10+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_25.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-9/2015-04-22T22:02:37+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_29.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-10/2015-04-22T22:03:03+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_19.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-11/2015-04-22T22:03:34+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_37.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-12/2015-04-22T22:03:59+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_46.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-13/2015-04-22T22:04:23+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_32.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-14/2015-04-22T22:04:52+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_50.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-15/2015-04-22T22:05:19+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_54.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-16/2015-04-22T22:05:46+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_47.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-17/2015-04-22T22:06:48+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_64.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-18/2015-04-22T22:07:10+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_61.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-19/2015-04-22T22:07:34+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_63.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-20/2015-04-22T22:08:01+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_80.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-21/2015-04-22T22:08:26+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_69.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-22/2015-04-22T22:08:51+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_71.jpghttps://timmermanreport.com/2015/04/see-the-photos-timmerman-report-east-coast-launch-party/ks041615\_timmermanreport\_-23/2015-04-22T22:09:10+00:00https://timmermanreport.com/wp-content/uploads/2015/04/timmerman\_72.jpghttps://timmermanreport.com/2015/04/academic-paternalism-has-got-to-go-its-time-to-re-invent-biotech-student-life/dougcrawford/2015-04-26T22:52:28+00:00https://timmermanreport.com/wp-content/uploads/2015/04/dougcrawford.jpghttps://timmermanreport.com/2015/04/qa-with-illumina-ceo-jay-flatley-on-building-a-genome-sequencing-powerhouse/jayflatley/2015-04-28T00:00:24+00:00https://timmermanreport.com/wp-content/uploads/2015/04/jayflatley.jpghttps://timmermanreport.com/2015/05/zigging-away-from-the-herd-lillys-road-less-traveled-rd-strategy/adahlem/2015-05-18T15:20:14+00:00https://timmermanreport.com/wp-content/uploads/2015/05/adahlem.jpghttps://timmermanreport.com/2015/05/why-a-pfizer-rd-exec-joined-little-synlogic-to-make-therapeutic-synthetic-life/jcgr/2015-05-21T14:05:50+00:00https://timmermanreport.com/wp-content/uploads/2015/05/jcgr.pnghttps://timmermanreport.com/2015/05/the-genentech-alumni-where-are-they-now/arthur-levinson/2015-05-21T23:36:03+00:00https://timmermanreport.com/wp-content/uploads/2015/05/arthur-levinson-e1432251389665.jpghttps://timmermanreport.com/2015/05/long-term-relationships-may-not-pay-in-many-businesses-but-they-still-do-in-biotech/bio-mark-levin-sm/2015-05-22T21:24:04+00:00https://timmermanreport.com/wp-content/uploads/2015/05/bio-mark-levin-sm-e1432329834267.jpghttps://timmermanreport.com/2015/06/big-pharma-talent-is-flocking-to-biotech-startups-nobodys-saying-are-you-nuts/cwilson/2015-05-29T20:17:50+00:00https://timmermanreport.com/wp-content/uploads/2015/05/cwilson.pnghttps://timmermanreport.com/2015/06/cancer-is-hot-diabetes-is-not-watch-for-safety-and-costs-at-next-medical-meeting/dbradbury/2015-06-04T19:49:04+00:00https://timmermanreport.com/wp-content/uploads/2015/06/dbradbury.jpghttps://timmermanreport.com/2015/06/bristol-myers-should-drop-the-bully-act-non-competes-are-bad-for-biotech/brucemontgomery-1-sm1/2015-06-05T19:23:54+00:00https://timmermanreport.com/wp-content/uploads/2015/06/BruceMontgomery-1-sm1.jpghttps://timmermanreport.com/2015/06/its-time-to-re-think-some-assumptions-about-cancer-rd/disis/2015-06-14T23:19:54+00:00https://timmermanreport.com/wp-content/uploads/2015/06/disis.jpghttps://timmermanreport.com/2015/06/its-time-to-re-think-some-assumptions-about-cancer-rd/cheever/2015-06-14T23:21:00+00:00https://timmermanreport.com/wp-content/uploads/2015/06/cheever.jpghttps://timmermanreport.com/2015/06/whos-exploring-dna-dark-matter-for-drug-discovery/jstam4/2015-06-18T20:58:53+00:00https://timmermanreport.com/wp-content/uploads/2015/06/jstam4.jpghttps://timmermanreport.com/2015/06/like-the-tr-tell-a-friend-to-subscribe-and-enter-to-win-a-t-shirt/timmerman-launch-20mar15-332/2015-06-19T17:36:50+00:00https://timmermanreport.com/wp-content/uploads/2015/06/timmerman-launch-20mar15-332-e1434735450858.jpghttps://timmermanreport.com/2015/06/a-small-dose-of-hope-for-our-old-fashioned-drug-safety-surveillance-system/jsegal/2015-06-20T00:39:04+00:00https://timmermanreport.com/wp-content/uploads/2015/06/jsegal-e1434760765682.jpghttps://timmermanreport.com/2015/06/linkedin-is-woven-into-the-fabric-of-biotech-but-some-top-people-still-dont-get-it/bg-photo-oct-2014/2015-06-28T20:28:47+00:00https://timmermanreport.com/wp-content/uploads/2015/06/BG-photo-Oct-2014.jpghttps://timmermanreport.com/2015/06/linkedin-is-woven-into-the-fabric-of-biotech-but-some-top-people-still-dont-get-it/flemming-ornskov/2015-06-28T21:18:30+00:00https://timmermanreport.com/wp-content/uploads/2015/06/Flemming-Ornskov-e1435526336338.pnghttps://timmermanreport.com/2015/07/forget-price-controls-value-based-pricing-is-the-new-threat-to-drug-development/twilson/2015-07-17T03:40:43+00:00https://timmermanreport.com/wp-content/uploads/2015/07/twilson.jpghttps://timmermanreport.com/2015/07/the-non-compete-chill-has-passed-bristol-myers-medimmune-settle-over-i-o-star/david-berman-225/2015-07-21T21:15:45+00:00https://timmermanreport.com/wp-content/uploads/2015/07/David-Berman-225.jpghttps://timmermanreport.com/events/timmerman-launch-20mar15-332-2/2015-07-27T20:26:10+00:00https://timmermanreport.com/wp-content/uploads/2014/12/timmerman-launch-20mar15-332.jpghttps://timmermanreport.com/events/timmerman-launch-20mar15-228/2015-07-27T20:35:56+00:00https://timmermanreport.com/wp-content/uploads/2014/12/timmerman-launch-20mar15-228.jpghttps://timmermanreport.com/events/timmerman-launch-20mar15-228-2/2015-07-27T20:38:56+00:00https://timmermanreport.com/wp-content/uploads/2014/12/timmerman-launch-20mar15-2281-e1442863105242.jpghttps://timmermanreport.com/2015/07/join-me-for-tr-subscriber-meetup-aug-5-in-kendall-square/ks041615\_timmermanreport\_-24/2015-07-30T18:00:13+00:00https://timmermanreport.com/wp-content/uploads/2015/07/timmerman\_67.jpghttps://timmermanreport.com/2015/08/making-biotech-drugs-people-can-afford-kuow-radio-segment/jim-thomas/2015-08-06T10:14:23+00:00https://timmermanreport.com/wp-content/uploads/2015/08/JIm-Thomas-e1438856112533.jpghttps://timmermanreport.com/2015/08/pharmaphobia-makes-important-counterargument-but-falls-short/tstossel/2015-08-07T23:10:15+00:00https://timmermanreport.com/wp-content/uploads/2015/08/tstossel.jpghttps://timmermanreport.com/events/ks041615\_timmermanreport\_-25/2015-08-10T20:20:54+00:00https://timmermanreport.com/wp-content/uploads/2014/12/timmerman\_67.jpghttps://timmermanreport.com/2015/08/important-note-for-tr-subscribers-please-re-register/timmerman-report-logo-3/2015-08-12T22:27:28+00:00https://timmermanreport.com/wp-content/uploads/2015/08/timmerman-report-logo-e1439418496141.jpghttps://timmermanreport.com/2015/08/amarin-vs-the-fda-on-free-speech-a-careful-what-you-wish-for-moment/phutt/2015-08-14T19:57:32+00:00https://timmermanreport.com/wp-content/uploads/2015/08/phutt.jpghttps://timmermanreport.com/2015/08/a-day-in-the-life-of-a-biotech-building-1616-eastlake/attachment/1616/2015-08-20T01:08:34+00:00https://timmermanreport.com/wp-content/uploads/2015/08/1616.jpghttps://timmermanreport.com/2015/08/a-day-in-the-life-of-a-biotech-building-1616-eastlake/cpaya/2015-08-20T01:12:39+00:00https://timmermanreport.com/wp-content/uploads/2015/08/cpaya.pnghttps://timmermanreport.com/2015/08/a-day-in-the-life-of-a-biotech-building-1616-eastlake/tfoy/2015-08-20T01:14:54+00:00https://timmermanreport.com/wp-content/uploads/2015/08/tfoy.pnghttps://timmermanreport.com/2015/08/informed-consent-isnt-working-sage-apple-just-might-be-onto-something/jwilbanks/2015-08-20T19:54:05+00:00https://timmermanreport.com/wp-content/uploads/2015/08/jwilbanks.jpghttps://timmermanreport.com/2015/08/informed-consent-isnt-working-sage-apple-just-might-be-onto-something/mmeyer/2015-08-20T19:55:28+00:00https://timmermanreport.com/wp-content/uploads/2015/08/mmeyer.pnghttps://timmermanreport.com/2015/08/what-happens-after-the-hype-a-few-survive-the-trough/andrewhirsch/2015-08-29T00:11:12+00:00https://timmermanreport.com/wp-content/uploads/2015/08/andrewhirsch.jpghttps://timmermanreport.com/2015/08/what-happens-after-the-hype-a-few-survive-the-trough/alny5year/2015-08-29T00:41:54+00:00https://timmermanreport.com/wp-content/uploads/2015/08/alny5year.pnghttps://timmermanreport.com/2015/09/join-me-for-the-tr-san-francisco-launch-party-oct-20/2014-07-13-19-58-19/2015-08-31T18:33:13+00:00https://timmermanreport.com/wp-content/uploads/2015/08/2014-07-13-19.58.19-e1442862953546.jpghttps://timmermanreport.com/2015/09/join-me-for-the-tr-san-francisco-launch-party-oct-20/ks041615\_timmermanreport\_-26/2015-08-31T18:42:37+00:00https://timmermanreport.com/wp-content/uploads/2015/08/timmerman\_46-e1441046696447.jpghttps://timmermanreport.com/2015/09/medical-device-innovation-is-on-life-support-what-will-revive-it/nimesh-shah/2015-09-04T20:52:28+00:00https://timmermanreport.com/wp-content/uploads/2015/09/nimesh-shah.jpghttps://timmermanreport.com/2015/09/medical-device-innovation-is-on-life-support-what-will-revive-it/medtechpwc/2015-09-04T21:00:46+00:00https://timmermanreport.com/wp-content/uploads/2015/09/medtechpwc.pnghttps://timmermanreport.com/2015/09/medical-device-innovation-is-on-life-support-what-will-revive-it/biotechfundspwc/2015-09-04T21:01:56+00:00https://timmermanreport.com/wp-content/uploads/2015/09/biotechfundspwc.pnghttps://timmermanreport.com/2015/09/medical-device-innovation-is-on-life-support-what-will-revive-it/tclement/2015-09-04T21:16:10+00:00https://timmermanreport.com/wp-content/uploads/2015/09/tclement.jpghttps://timmermanreport.com/2015/09/post-labor-day-hangovers-ipi-nivo-combo-data-the-pcsk9-pricing-debate/frontpoints/2015-09-10T21:26:29+00:00https://timmermanreport.com/wp-content/uploads/2015/09/frontpoints-e1441920420307.pnghttps://timmermanreport.com/2015/09/more-than-just-science-relationships-between-vcs-and-pharma-drive-deals/bryanroberts/2015-09-11T21:49:38+00:00https://timmermanreport.com/wp-content/uploads/2015/01/bryanroberts.jpghttps://timmermanreport.com/2015/09/new-fda-commish-lillys-diabetes-stunner-and-a-dust-up-over-immortality/llyjardiance/2015-09-18T13:30:27+00:00https://timmermanreport.com/wp-content/uploads/2015/09/llyjardiance-e1442582995744.pnghttps://timmermanreport.com/2015/09/the-mckinsey-alumni-where-are-they-wielding-influence/mikepearson/2015-09-19T19:31:22+00:00https://timmermanreport.com/wp-content/uploads/2015/09/mikepearson.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-124/2015-09-21T19:12:39+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-124-e1442862805746.jpghttps://timmermanreport.com/2015/03/see-the-photos-timmerman-report-west-coast-launch-party/timmerman-launch-20mar15-153/2015-09-21T19:20:31+00:00https://timmermanreport.com/wp-content/uploads/2015/03/timmerman-launch-20mar15-153.jpghttps://timmermanreport.com/2015/09/a-timeline-of-the-turing-pharma-pricing-controversy/drugspending/2015-09-23T18:34:08+00:00https://timmermanreport.com/wp-content/uploads/2015/09/drugspending-e1443033351701.pnghttps://timmermanreport.com/2015/09/pharma-gouging-got-everyones-attention-now-its-time-to-re-imagine-fair-pricing/praveen/2015-09-28T00:30:53+00:00https://timmermanreport.com/wp-content/uploads/2015/09/praveen.jpghttps://timmermanreport.com/2015/10/the-next-macro-phage-thing-in-immuno-oncology/vitopalombella/2015-09-30T22:49:28+00:00https://timmermanreport.com/wp-content/uploads/2015/09/VitoPalombella.jpghttps://timmermanreport.com/2015/10/glaxosmithkline-a-bunch-of-numbskulls-or-crazy-like-a-fox/sir-andrew-witty/2015-10-02T22:52:37+00:00https://timmermanreport.com/wp-content/uploads/2015/10/sir-andrew-witty.jpghttps://timmermanreport.com/2015/10/glaxosmithkline-a-bunch-of-numbskulls-or-crazy-like-a-fox/gskvsmrkvspfe/2015-10-02T22:53:58+00:00https://timmermanreport.com/wp-content/uploads/2015/10/gskvsmrkvspfe-e1443826526156.jpghttps://timmermanreport.com/2015/10/introducing-signal-the-stat-podcast-im-co-hosting-with-meg-tirrell/signalimage/2015-10-14T18:02:32+00:00https://timmermanreport.com/wp-content/uploads/2015/10/signalimage.jpghttps://timmermanreport.com/2015/10/investors-shouldnt-nitpick-old-data-bluebirds-new-gene-therapy-vector-makes-a-difference/zackfink/2015-10-23T01:02:06+00:00https://timmermanreport.com/wp-content/uploads/2015/10/zackfink.pnghttps://timmermanreport.com/2015/10/investors-shouldnt-nitpick-old-data-bluebirds-new-gene-therapy-vector-makes-a-difference/fink1/2015-10-23T01:09:10+00:00https://timmermanreport.com/wp-content/uploads/2015/10/fink1-e1445562575741.jpghttps://timmermanreport.com/2015/10/investors-shouldnt-nitpick-old-data-bluebirds-new-gene-therapy-vector-makes-a-difference/fink2/2015-10-23T01:11:40+00:00https://timmermanreport.com/wp-content/uploads/2015/10/fink2-e1445562711720.jpghttps://timmermanreport.com/2015/10/investors-shouldnt-nitpick-old-data-bluebirds-new-gene-therapy-vector-makes-a-difference/fink3/2015-10-23T01:12:57+00:00https://timmermanreport.com/wp-content/uploads/2015/10/fink3.jpghttps://timmermanreport.com/2015/10/investors-shouldnt-nitpick-old-data-bluebirds-new-gene-therapy-vector-makes-a-difference/fink4/2015-10-23T01:14:17+00:00https://timmermanreport.com/wp-content/uploads/2015/10/fink4-e1445562869765.jpghttps://timmermanreport.com/2015/10/biotech-and-pharma-need-to-find-more-on-ramps-for-young-people/mgladstone/2015-10-23T20:38:58+00:00https://timmermanreport.com/wp-content/uploads/2015/10/mgladstone.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-008/2015-10-26T18:05:19+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-008.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-009/2015-10-26T18:06:04+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-009.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-011/2015-10-26T18:06:09+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-011.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-015/2015-10-26T18:06:14+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-015.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-046/2015-10-26T18:08:29+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-046.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-062/2015-10-26T18:08:34+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-062.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-063/2015-10-26T18:08:40+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-063.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-067/2015-10-26T18:08:43+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-067.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-068/2015-10-26T18:08:48+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-068.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-074/2015-10-26T18:08:53+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-074.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-076/2015-10-26T18:08:58+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-076.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-077/2015-10-26T18:09:02+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-077.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-083/2015-10-26T18:11:51+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-083.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-084/2015-10-26T18:11:56+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-084.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-093/2015-10-26T18:12:01+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-093.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-111/2015-10-26T18:12:07+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-111.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-117/2015-10-26T18:12:11+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-117.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-123/2015-10-26T18:12:14+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-123.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-125/2015-10-26T18:12:18+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-125.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-160/2015-10-26T18:12:22+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-160.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-162/2015-10-26T18:12:27+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-162.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-167/2015-10-26T18:12:31+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-167.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-183/2015-10-26T18:12:35+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-183.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-193/2015-10-26T18:12:40+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-193.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-196/2015-10-26T18:12:45+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-196.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-200/2015-10-26T18:12:50+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-200.jpghttps://timmermanreport.com/2015/10/see-the-photos-from-the-tr1k-party-in-sf/timmerman\_launch\_2015-186/2015-10-26T18:18:09+00:00https://timmermanreport.com/wp-content/uploads/2015/10/timmerman\_launch\_2015-186.jpghttps://timmermanreport.com/2015/10/pfizers-new-megamerger-target-valeant-squirms-amgens-cancer-advance/loncarft/2015-10-29T20:45:32+00:00https://timmermanreport.com/wp-content/uploads/2015/10/loncarft.jpghttps://timmermanreport.com/about-luke-timmerman/fastercuresrichardpops/2015-11-06T03:40:18+00:00https://timmermanreport.com/wp-content/uploads/2014/12/fastercuresRichardPops.jpghttps://timmermanreport.com/2015/11/pursuing-a-hard-cancer-target-qa-with-warp-drive-ceo-laurence-reid/lreid/2015-11-10T03:31:55+00:00https://timmermanreport.com/wp-content/uploads/2015/11/lreid.pnghttps://timmermanreport.com/about-luke-timmerman/timmerman\_launch\_2015-012/2015-11-10T03:53:02+00:00https://timmermanreport.com/wp-content/uploads/2014/12/timmerman\_launch\_2015-012.jpghttps://timmermanreport.com/about-luke-timmerman/timmerman\_launch\_2015-185/2015-11-10T03:57:03+00:00https://timmermanreport.com/wp-content/uploads/2014/12/timmerman\_launch\_2015-185.jpghttps://timmermanreport.com/events/timmerman\_launch\_2015-131/2015-11-10T03:59:35+00:00https://timmermanreport.com/wp-content/uploads/2014/12/timmerman\_launch\_2015-131.jpghttps://timmermanreport.com/2015/11/a-new-social-contract-in-pharma-qa-with-alnylams-john-maraganore/jm-2/2015-11-15T22:50:56+00:00https://timmermanreport.com/wp-content/uploads/2015/11/jm.pnghttps://timmermanreport.com/2015/11/reimaging-the-scientific-enterprise-qa-with-mits-bob-langer/p\_faculty\_r\_langer/2015-11-20T22:53:40+00:00https://timmermanreport.com/wp-content/uploads/2015/11/p\_faculty\_r\_langer.jpghttps://timmermanreport.com/2015/11/free-speech-in-pharma-should-be-for-rd-people-too-not-just-sales-marketing/derek-lowe1-e1435835132452/2015-11-28T21:35:14+00:00https://timmermanreport.com/wp-content/uploads/2015/11/Derek-Lowe1-e1435835132452.jpghttps://timmermanreport.com/readers-saying/dsable/2015-12-03T17:26:37+00:00https://timmermanreport.com/wp-content/uploads/2015/01/dsable.jpghttps://timmermanreport.com/2015/12/why-im-not-buying-any-consumer-genetic-tests-this-holiday-season/brooksdyad/2015-12-12T22:24:29+00:00https://timmermanreport.com/wp-content/uploads/2015/12/brooksdyad.jpghttps://timmermanreport.com/2015/12/why-im-not-buying-any-consumer-genetic-tests-this-holiday-season/brooksdyad7/2015-12-12T22:42:51+00:00https://timmermanreport.com/wp-content/uploads/2015/12/brooksdyad7.jpghttps://timmermanreport.com/2015/12/what-technologies-were-hyped-and-which-came-down-a-notch-in-2015/dzohar/2015-12-21T01:02:55+00:00https://timmermanreport.com/wp-content/uploads/2015/12/dzohar.jpghttps://timmermanreport.com/2015/12/what-technologies-were-hyped-and-which-came-down-a-notch-in-2015/gartnerhype/2015-12-21T01:13:24+00:00https://timmermanreport.com/wp-content/uploads/2015/12/GartnerHype.jpghttps://timmermanreport.com/2015/12/what-technologies-were-hyped-and-which-came-down-a-notch-in-2015/pacb/2015-12-21T02:09:45+00:00https://timmermanreport.com/wp-content/uploads/2015/12/pacb.jpghttps://timmermanreport.com/2016/01/competition-by-itself-isnt-enough-to-corral-drug-prices/roger-longman/2015-12-27T01:11:47+00:00https://timmermanreport.com/wp-content/uploads/2015/12/roger-longman.jpghttps://timmermanreport.com/2016/01/all-the-biotech-deals-and-financings-you-can-grok-before-jp-morgan-2016/meggileadprices/2016-01-08T00:59:47+00:00https://timmermanreport.com/wp-content/uploads/2016/01/meggileadprices.jpghttps://timmermanreport.com/2016/01/all-the-biotech-deals-and-financings-you-can-grok-before-jp-morgan-2016/loncarsecondarydiscounts/2016-01-08T01:07:16+00:00https://timmermanreport.com/wp-content/uploads/2016/01/loncarsecondarydiscounts.jpghttps://timmermanreport.com/2016/01/go-go-years-have-been-good-for-biotech-but-service-providers-are-feeling-the-strain/aj/2016-01-09T21:11:46+00:00https://timmermanreport.com/wp-content/uploads/2016/01/aj.pnghttps://timmermanreport.com/2016/01/go-go-years-have-been-good-for-biotech-but-service-providers-are-feeling-the-strain/sg/2016-01-09T21:13:48+00:00https://timmermanreport.com/wp-content/uploads/2016/01/sg.pnghttps://timmermanreport.com/2016/01/go-go-years-have-been-good-for-biotech-but-service-providers-are-feeling-the-strain/gg/2016-01-09T21:15:35+00:00https://timmermanreport.com/wp-content/uploads/2016/01/gg.pnghttps://timmermanreport.com/2015/04/academic-paternalism-has-got-to-go-its-time-to-re-invent-biotech-student-life/thong-le-2/2016-01-09T21:16:52+00:00https://timmermanreport.com/wp-content/uploads/2015/01/Thong-Le-e1452374194718.jpghttps://timmermanreport.com/2016/02/drugmakers-are-lousy-at-communicating-heres-how-to-improve/tcoles/2016-02-16T00:00:17+00:00https://timmermanreport.com/wp-content/uploads/2016/02/tcoles.jpghttps://timmermanreport.com/2016/02/drugmakers-are-lousy-at-communicating-heres-how-to-improve/jm-3/2016-02-16T00:25:57+00:00https://timmermanreport.com/wp-content/uploads/2016/02/jm.pnghttps://timmermanreport.com/2016/02/intercept-rumors-alnylams-200m-factory-and-some-precious-ebola-antibodies/drewtweet1/2016-02-19T02:44:53+00:00https://timmermanreport.com/wp-content/uploads/2016/02/drewtweet1.jpghttps://timmermanreport.com/2016/02/one-way-to-improve-clinical-trials-a-yelp-style-rating-system/happyemoji/2016-02-19T19:12:52+00:00https://timmermanreport.com/wp-content/uploads/2016/02/happyemoji.pnghttps://timmermanreport.com/2016/02/one-way-to-improve-clinical-trials-a-yelp-style-rating-system/sademoji/2016-02-19T19:13:30+00:00https://timmermanreport.com/wp-content/uploads/2016/02/sademoji.pnghttps://timmermanreport.com/2016/02/actives-vs-zombies-dysfunctional-boards-are-haunting-biotech-and-messing-with-ma/janderson/2016-02-19T23:12:16+00:00https://timmermanreport.com/wp-content/uploads/2016/02/janderson.jpghttps://timmermanreport.com/2016/02/actives-vs-zombies-dysfunctional-boards-are-haunting-biotech-and-messing-with-ma/oded/2016-02-20T00:04:17+00:00https://timmermanreport.com/wp-content/uploads/2016/02/oded.jpghttps://timmermanreport.com/2016/02/merck-nanostring-seek-to-identify-i-o-responders-in-rich-companion-dx-deal/bgray/2016-02-29T20:05:31+00:00https://timmermanreport.com/wp-content/uploads/2016/02/bgray.jpghttps://timmermanreport.com/2016/03/trumps-so-called-healthcare-plan-valeant-boss-returns-and-gileads-good-week/frontpoints-2/2016-03-04T17:42:45+00:00https://timmermanreport.com/wp-content/uploads/2016/03/frontpoints.pnghttps://timmermanreport.com/2016/03/draft-joe-biden-and-roy-vagelos-for-a-fair-deal-on-drug-pricing/vp\_portrait\_lores/2016-03-05T22:48:47+00:00https://timmermanreport.com/wp-content/uploads/2016/03/vp\_portrait\_lores-e1457218213907.jpeghttps://timmermanreport.com/2016/03/draft-joe-biden-and-roy-vagelos-for-a-fair-deal-on-drug-pricing/susan\_desmond\_hellmann\_227x154/2016-03-05T22:57:48+00:00https://timmermanreport.com/wp-content/uploads/2016/03/Susan\_Desmond\_Hellmann\_227x154.jpghttps://timmermanreport.com/2016/03/draft-joe-biden-and-roy-vagelos-for-a-fair-deal-on-drug-pricing/steve\_ubl/2016-03-05T23:09:06+00:00https://timmermanreport.com/wp-content/uploads/2016/03/steve\_ubl.jpghttps://timmermanreport.com/2016/03/subscribers-come-celebrate-at-the-tr-one-year-anniversary-party/ks041615\_timmermanreport\_-27/2016-03-07T00:22:09+00:00https://timmermanreport.com/wp-content/uploads/2016/03/timmerman\_44.jpghttps://timmermanreport.com/2016/03/subscribers-come-celebrate-at-the-tr-one-year-anniversary-party/ks041615\_timmermanreport\_-28/2016-03-07T00:23:00+00:00https://timmermanreport.com/wp-content/uploads/2016/03/timmerman\_46.jpghttps://timmermanreport.com/2016/03/learn-or-die/joinordie/2016-03-07T19:41:37+00:00https://timmermanreport.com/wp-content/uploads/2016/03/joinordie.jpghttps://timmermanreport.com/2016/03/learn-or-die/jocelyn/2016-03-07T19:43:44+00:00https://timmermanreport.com/wp-content/uploads/2016/03/jocelyn.jpghttps://timmermanreport.com/2016/03/learn-or-die/file-jenny-mccarthy-to-co-host-the-view/2016-03-07T19:45:51+00:00https://timmermanreport.com/wp-content/uploads/2016/03/jennymccarthy.jpghttps://timmermanreport.com/2016/03/sanofi-bets-50m-on-dice-a-directed-evolution-twist-on-drug-discovery/photo\_katherine-bowdish/2016-03-15T22:56:18+00:00https://timmermanreport.com/wp-content/uploads/2016/03/photo\_katherine-bowdish.jpghttps://timmermanreport.com/2016/03/qa-drug-pricing-gileads-gregg-alton-outtakes-signal/alton/2016-03-16T23:30:10+00:00https://timmermanreport.com/wp-content/uploads/2016/03/Alton.jpghttps://timmermanreport.com/2016/03/valeant-finally-collapses-carl-junes-curious-omission-wittys-swan-song/celator/2016-03-18T01:30:09+00:00https://timmermanreport.com/wp-content/uploads/2016/03/celator.jpghttps://timmermanreport.com/2016/03/no-peanuts-tweeds-merck-rightly-pays-harvard-20m-cancer-drug/isaacsmall\_146\_146\_all\_-72\_c1/2016-03-20T23:01:14+00:00https://timmermanreport.com/wp-content/uploads/2016/03/IsaacSmall\_146\_146\_all\_-72\_c1.pnghttps://timmermanreport.com/2016/03/make-sense-acqui-hire-biotech/john-mendlein/2016-03-26T17:24:40+00:00https://timmermanreport.com/wp-content/uploads/2015/01/John-Mendlein.jpghttps://timmermanreport.com/2016/03/join-tr-stat-conversation-health-science-journalism/rick-berke\_avatar\_1446145329/2016-03-30T19:40:25+00:00https://timmermanreport.com/wp-content/uploads/2016/03/Rick-Berke\_avatar\_1446145329.jpghttps://timmermanreport.com/2016/04/pfizergan-unravels-gilead-gets-nash-drug-verily-self-dealing/vrtxchart/2016-04-07T23:36:18+00:00https://timmermanreport.com/wp-content/uploads/2016/04/vrtxchart.jpghttps://timmermanreport.com/2016/04/12-vcs-matter-never-read/anand/2016-04-08T20:48:11+00:00https://timmermanreport.com/wp-content/uploads/2016/04/anand.jpghttps://timmermanreport.com/2016/04/12-vcs-matter-never-read/kim-kamdar/2016-04-08T20:49:02+00:00https://timmermanreport.com/wp-content/uploads/2016/04/kim-kamdar.jpghttps://timmermanreport.com/2016/04/12-vcs-matter-never-read/albert\_cha/2016-04-08T20:50:17+00:00https://timmermanreport.com/wp-content/uploads/2016/04/albert\_cha.jpghttps://timmermanreport.com/2016/04/12-vcs-matter-never-read/larry\_lasky\_lrg/2016-04-08T20:55:14+00:00https://timmermanreport.com/wp-content/uploads/2016/04/Larry\_Lasky\_LRG-e1460148867823.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0172/2016-04-19T14:57:45+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0172.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0182/2016-04-19T14:57:54+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0182.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0187/2016-04-19T14:58:07+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0187.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0191/2016-04-19T14:58:19+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0191.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0195/2016-04-19T14:58:32+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0195.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0205/2016-04-19T14:58:42+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0205.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0207/2016-04-19T14:58:51+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0207.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0217/2016-04-19T14:59:03+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0217.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0225/2016-04-19T14:59:13+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0225.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0229/2016-04-19T14:59:22+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0229.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0230/2016-04-19T14:59:30+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0230.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0236/2016-04-19T14:59:40+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0236.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0237/2016-04-19T14:59:50+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0237.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0250/2016-04-19T15:00:03+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0250.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0251/2016-04-19T15:00:19+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0251.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0253/2016-04-19T15:00:34+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0253.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0271/2016-04-19T15:00:43+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0271.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0278/2016-04-19T15:00:53+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0278.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0290/2016-04-19T15:01:01+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0290-e1461078380928.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0292/2016-04-19T15:01:11+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0292.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0294/2016-04-19T15:01:22+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0294.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0307/2016-04-19T15:01:33+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0307.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0317/2016-04-19T15:01:42+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0317.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0322/2016-04-19T15:01:51+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0322.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0328/2016-04-19T15:02:00+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0328-e1461078415190.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0331/2016-04-19T15:02:08+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0331.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0333/2016-04-19T15:02:17+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0333.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0342/2016-04-19T15:02:26+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0342.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0349/2016-04-19T15:02:36+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0349.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0350/2016-04-19T15:02:47+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0350.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0356/2016-04-19T15:02:55+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0356.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0360/2016-04-19T15:03:03+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0360.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0373/2016-04-19T15:03:13+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0373.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0375/2016-04-19T15:03:22+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0375.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0385/2016-04-19T15:03:35+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0385.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0386/2016-04-19T15:03:45+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0386.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0393/2016-04-19T15:03:54+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0393.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0396/2016-04-19T15:04:07+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0396.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0397/2016-04-19T15:04:21+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0397.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0403/2016-04-19T15:04:32+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0403.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0412/2016-04-19T15:04:41+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0412.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0416/2016-04-19T15:04:51+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0416.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0418/2016-04-19T15:05:01+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0418.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/bostonmarathon2016/2016-04-19T15:21:04+00:00https://timmermanreport.com/wp-content/uploads/2016/04/bostonmarathon2016.jpghttps://timmermanreport.com/2016/04/see-photos-tr-anniversary-party-boston/dsc\_0360-2/2016-04-19T18:55:22+00:00https://timmermanreport.com/wp-content/uploads/2016/04/DSC\_0360-1.jpghttps://timmermanreport.com/2016/04/theranos-trigger-event-just-might-bring-order-diagnostic-wild-west/bonnie/2016-04-22T21:26:51+00:00https://timmermanreport.com/wp-content/uploads/2016/04/bonnie.jpghttps://timmermanreport.com/speaking-2/video-thumb/2016-05-21T04:11:02+00:00https://timmermanreport.com/wp-content/uploads/2016/05/video-thumb.jpghttps://timmermanreport.com/speaking-2/logo-kuow-2/2016-05-21T05:13:27+00:00https://timmermanreport.com/wp-content/uploads/2016/05/logo-kuow.pnghttps://timmermanreport.com/2016/05/regeneron-supports-youth-science-minerva-nails-schizophrenia-trial-sarepta-waits/jain/2016-05-27T01:24:58+00:00https://timmermanreport.com/wp-content/uploads/2016/05/jain.jpghttps://timmermanreport.com/in-the-news/logo-ksj/2016-06-02T05:26:24+00:00https://timmermanreport.com/wp-content/uploads/2016/03/logo-ksj.pnghttps://timmermanreport.com/2016/06/asco-preview-biomarins-monster-dmd-write-superbug-wakeup-call/flex/2016-06-03T00:27:42+00:00https://timmermanreport.com/wp-content/uploads/2016/06/flex.jpghttps://timmermanreport.com/2016/06/bigger-better-biotech-venture-capital/schwab-175x197/2016-06-03T23:08:33+00:00https://timmermanreport.com/wp-content/uploads/2016/06/Schwab-175x197.pnghttps://timmermanreport.com/about-luke-timmerman/thespringboard/2016-06-06T03:17:39+00:00https://timmermanreport.com/wp-content/uploads/2014/12/thespringboard.jpghttps://timmermanreport.com/about-luke-timmerman/trspringboard/2016-06-06T03:22:50+00:00https://timmermanreport.com/wp-content/uploads/2014/12/trspringboard.pnghttps://timmermanreport.com/2016/06/bio-jabs-payers-jennifer-l-merck-buys-afferent/bls/2016-06-10T14:02:25+00:00https://timmermanreport.com/wp-content/uploads/2016/06/bls.pnghttps://timmermanreport.com/2016/06/bio-shows-newt-love-backdoor-influence-trump-administration/greenwood\_jim\_3163\_crop/2016-06-10T21:40:15+00:00https://timmermanreport.com/wp-content/uploads/2016/06/Greenwood\_Jim\_3163\_crop.jpghttps://timmermanreport.com/about-luke-timmerman/lukeboston2016gilman/2016-06-11T16:14:23+00:00https://timmermanreport.com/wp-content/uploads/2014/12/lukeboston2016gilman.jpghttps://timmermanreport.com/2016/06/the-schreiberians-where-are-they-now/stuart\_schreiber/2016-06-13T18:08:24+00:00https://timmermanreport.com/wp-content/uploads/2016/06/stuart\_schreiber.jpghttps://timmermanreport.com/2016/06/7003/jeb/2016-06-17T00:57:25+00:00https://timmermanreport.com/wp-content/uploads/2016/06/jeb.pnghttps://timmermanreport.com/2016/06/obama-toys-precision-med-job-gates-shines-light-superbugs-parker-angles-crispr-trial/nihalzheimers/2016-06-23T21:43:42+00:00https://timmermanreport.com/wp-content/uploads/2016/06/nihalzheimers.pnghttps://timmermanreport.com/2016/06/vp-calling-advice-cancer-tell-go-dc/vp\_portrait/2016-06-24T19:04:18+00:00https://timmermanreport.com/wp-content/uploads/2016/06/vp\_portrait-e1466795097383.jpeghttps://timmermanreport.com/2015/09/pharma-gouging-got-everyones-attention-now-its-time-to-re-imagine-fair-pricing/praveen-2/2016-06-29T02:09:24+00:00https://timmermanreport.com/wp-content/uploads/2015/09/praveen.pnghttps://timmermanreport.com/2016/07/high-powered-peter-schultz-lab-alumni-see-now/pete-schultz-wide/2016-07-01T19:26:15+00:00https://timmermanreport.com/wp-content/uploads/2016/07/pete-schultz-wide-e1467401156622.jpghttps://timmermanreport.com/2016/07/juno-deaths-amgen-aims-humira-obamas-1m-citizen-scientist-dream/nelsentweet/2016-07-08T15:40:47+00:00https://timmermanreport.com/wp-content/uploads/2016/07/nelsentweet.pnghttps://timmermanreport.com/2016/07/juno-deaths-amgen-aims-humira-obamas-1m-citizen-scientist-dream/brennantweet/2016-07-08T15:48:16+00:00https://timmermanreport.com/wp-content/uploads/2016/07/brennantweet.pnghttps://timmermanreport.com/2016/07/juno-deaths-amgen-aims-humira-obamas-1m-citizen-scientist-dream/suetweet/2016-07-08T15:48:59+00:00https://timmermanreport.com/wp-content/uploads/2016/07/suetweet.pnghttps://timmermanreport.com/2016/07/best-boring-companies-biotech/seagenchart/2016-07-08T20:30:55+00:00https://timmermanreport.com/wp-content/uploads/2016/07/seagenchart.pnghttps://timmermanreport.com/2016/07/best-boring-companies-biotech/irwdchart/2016-07-08T20:33:35+00:00https://timmermanreport.com/wp-content/uploads/2016/07/irwdchart.pnghttps://timmermanreport.com/2016/07/another-alzheimers-whiff-biomarin-nails-gene-therapy-hemophilia-seres-meltdown/bradhcv/2016-07-29T18:15:23+00:00https://timmermanreport.com/wp-content/uploads/2016/07/bradhcv.pnghttps://timmermanreport.com/hood-book/hood-cover-front/2016-08-02T18:02:01+00:00https://timmermanreport.com/wp-content/uploads/2016/08/Hood-cover-front.jpghttps://timmermanreport.com/2016/08/7139/biibtakeover/2016-08-05T18:42:54+00:00https://timmermanreport.com/wp-content/uploads/2016/08/biibtakeover.pnghttps://timmermanreport.com/2016/08/watching-watchdog-icer-determine-fair-prices-drugs/lschiff/2016-08-11T16:29:52+00:00https://timmermanreport.com/wp-content/uploads/2016/08/lschiff.jpghttps://timmermanreport.com/2016/08/illumina-takeout-ha-portola-stumbles-nyts-biotech-dean-moves/andypollack/2016-08-19T17:26:59+00:00https://timmermanreport.com/wp-content/uploads/2016/08/andypollack.jpghttps://timmermanreport.com/2016/08/illumina-takeout-ha-portola-stumbles-nyts-biotech-dean-moves/ilmnaug18/2016-08-19T17:36:22+00:00https://timmermanreport.com/wp-content/uploads/2016/08/ilmnaug18.jpghttps://timmermanreport.com/2016/08/epipen-pricing-fury-pfizers-14b-megabid-medivation-denali-grabs-130m/dagros/2016-08-25T21:46:10+00:00https://timmermanreport.com/wp-content/uploads/2016/08/dagros.pnghttps://timmermanreport.com/2016/08/7218/roncohen/2016-08-27T20:53:46+00:00https://timmermanreport.com/wp-content/uploads/2016/08/roncohen.jpghttps://timmermanreport.com/2016/09/reflections-health-national-parks-epipens-foul-aftermath-saunders-steps/rockoff/2016-09-09T17:22:28+00:00https://timmermanreport.com/wp-content/uploads/2016/09/rockoff.pnghttps://timmermanreport.com/2016/09/saunders-delivers-powerful-reminder-industry-purpose-others-listening/saunders/2016-09-10T17:34:28+00:00https://timmermanreport.com/wp-content/uploads/2016/09/saunders.jpghttps://timmermanreport.com/2016/09/phil-sharps-review-hard-hitting-hood-biography-boston-book-launch-tour/hooduniv/2016-09-12T23:05:41+00:00https://timmermanreport.com/wp-content/uploads/2016/09/hooduniv.jpghttps://timmermanreport.com/2016/09/sareptas-controversial-victory-allergans-buying-spree-gsks-history-making-ceo/crisprsalaries/2016-09-21T22:56:12+00:00https://timmermanreport.com/wp-content/uploads/2016/09/crisprsalaries.pnghttps://timmermanreport.com/2016/09/much-novel-antibiotic-help-hillary-cempra-experiments-fair-price/prabha/2016-09-22T20:34:10+00:00https://timmermanreport.com/wp-content/uploads/2016/09/prabha.pnghttps://timmermanreport.com/2016/09/former-google-translate-star-leaves-venters-human-longevity-join-illuminas-grail/franz/2016-09-27T18:16:39+00:00https://timmermanreport.com/wp-content/uploads/2016/09/franz.jpghttps://timmermanreport.com/2016/09/gileads-bloom-fades-grail-poaches-data-star-kite-passes-big-car-t-trial/gp2016/2016-09-29T23:15:38+00:00https://timmermanreport.com/wp-content/uploads/2016/09/gp2016.jpghttps://timmermanreport.com/2016/09/gileads-bloom-fades-grail-poaches-data-star-kite-passes-big-car-t-trial/heroin-fentanyl-vials-nhspfl-1600x900/2016-09-29T23:39:35+00:00https://timmermanreport.com/wp-content/uploads/2016/09/Heroin-Fentanyl-vials-NHSPFL-1600x900.jpghttps://timmermanreport.com/2016/10/biotech-pr-boom-good-pr-business-not-good-industry-credibility/clindenboom/2016-10-03T00:05:38+00:00https://timmermanreport.com/wp-content/uploads/2016/10/clindenboom.jpghttps://timmermanreport.com/events/kochinstitute/2016-10-06T18:12:37+00:00https://timmermanreport.com/wp-content/uploads/2014/12/kochinstitute.jpghttps://timmermanreport.com/2016/10/alnylams-crash-theranos-strings-em-along-sareptas-deal-spree/ctic/2016-10-06T22:20:13+00:00https://timmermanreport.com/wp-content/uploads/2016/10/ctic.pnghttps://timmermanreport.com/2016/10/alnylams-crash-theranos-strings-em-along-sareptas-deal-spree/drug-pipeline-final/2016-10-06T23:35:05+00:00https://timmermanreport.com/wp-content/uploads/2016/10/kaisergraphic.jpghttps://timmermanreport.com/2016/10/bcg-alumni-wielding-influence-biotech-pharma/hannahchang/2016-10-07T18:35:36+00:00https://timmermanreport.com/wp-content/uploads/2016/10/hannahchang.jpghttps://timmermanreport.com/2016/10/bcg-alumni-wielding-influence-biotech-pharma/bcgfired/2016-10-07T18:45:59+00:00https://timmermanreport.com/wp-content/uploads/2016/10/bcgfired.jpghttps://timmermanreport.com/2016/10/bernie-fumes-ariad-overreach-alkermes-depression-drug-rebounds-ashg-notes/ariadtweet/2016-10-21T19:33:19+00:00https://timmermanreport.com/wp-content/uploads/2016/10/ariadtweet.pnghttps://timmermanreport.com/2016/10/bernie-fumes-ariad-overreach-alkermes-depression-drug-rebounds-ashg-notes/illuminatweet/2016-10-21T19:33:53+00:00https://timmermanreport.com/wp-content/uploads/2016/10/illuminatweet.pnghttps://timmermanreport.com/2016/10/bernie-fumes-ariad-overreach-alkermes-depression-drug-rebounds-ashg-notes/nordtweet/2016-10-21T19:35:50+00:00https://timmermanreport.com/wp-content/uploads/2016/10/nordtweet.pnghttps://timmermanreport.com/2016/10/amgen-banks-price-increases-humana-puts-sarepta-box-mit-starts-150m-engine/cohentweet/2016-10-28T03:25:05+00:00https://timmermanreport.com/wp-content/uploads/2016/10/cohentweet.jpghttps://timmermanreport.com/2016/11/pfizer-kills-psck9-drug-cempra-whiffs-calif-voters-take-aim-drug-prices/bernielilly/2016-11-04T01:33:58+00:00https://timmermanreport.com/wp-content/uploads/2016/11/bernielilly.pnghttps://timmermanreport.com/2016/11/pfizer-kills-psck9-drug-cempra-whiffs-calif-voters-take-aim-drug-prices/berniepeople/2016-11-04T01:35:00+00:00https://timmermanreport.com/wp-content/uploads/2016/11/berniepeople.pnghttps://timmermanreport.com/2016/11/pfizer-kills-psck9-drug-cempra-whiffs-calif-voters-take-aim-drug-prices/novolilly1/2016-11-04T01:36:03+00:00https://timmermanreport.com/wp-content/uploads/2016/11/novolilly1.pnghttps://timmermanreport.com/2016/11/pfizer-kills-psck9-drug-cempra-whiffs-calif-voters-take-aim-drug-prices/jacob/2016-11-04T01:39:32+00:00https://timmermanreport.com/wp-content/uploads/2016/11/jacob.pnghttps://timmermanreport.com/2016/11/pfizer-kills-psck9-drug-cempra-whiffs-calif-voters-take-aim-drug-prices/harlan/2016-11-04T01:40:09+00:00https://timmermanreport.com/wp-content/uploads/2016/11/harlan.pnghttps://timmermanreport.com/2016/11/dealing-megawatt-scientists-big-talkers-control-freaks-demigods/ninetypespis/2016-11-11T22:29:06+00:00https://timmermanreport.com/wp-content/uploads/2016/11/ninetypesPIs.jpghttps://timmermanreport.com/2016/04/12-vcs-matter-never-read/kristina\_burow2/2016-11-11T22:42:09+00:00https://timmermanreport.com/wp-content/uploads/2016/04/kristina\_burow2.jpghttps://timmermanreport.com/2016/11/sounding-alarm-brexit-uk-biotech-struggles-cope-isolationism/sdickman/2016-11-17T21:17:02+00:00https://timmermanreport.com/wp-content/uploads/2016/11/sdickman.jpghttps://timmermanreport.com/2016/11/7464/collinsplenary-2/2016-11-18T01:16:35+00:00https://timmermanreport.com/wp-content/uploads/2016/11/collinsplenary.jpghttps://timmermanreport.com/2016/11/pursuing-autism-gut-brain-axis-startup-axial-raises-19m/david\_donabedian/2016-11-30T00:04:26+00:00https://timmermanreport.com/wp-content/uploads/2016/11/David\_Donabedian.jpghttps://timmermanreport.com/2016/11/pursuing-autism-gut-brain-axis-startup-axial-raises-19m/michelle\_dipp-165/2016-11-30T00:06:54+00:00https://timmermanreport.com/wp-content/uploads/2016/11/Michelle\_Dipp-165.jpghttps://timmermanreport.com/2016/12/21st-century-cures-rolls-thru-house-price-poised-gut-obamacare-bluebird-soars/forbeshealth/2016-12-01T21:25:46+00:00https://timmermanreport.com/wp-content/uploads/2016/12/forbeshealth.pnghttps://timmermanreport.com/2016/12/21st-century-cures-rolls-thru-house-price-poised-gut-obamacare-bluebird-soars/nisen/2016-12-01T21:26:43+00:00https://timmermanreport.com/wp-content/uploads/2016/12/nisen.pnghttps://timmermanreport.com/2016/12/13-young-people-bucking-odds-finding-paths-break-biotech/armonsharei/2016-12-08T20:01:27+00:00https://timmermanreport.com/wp-content/uploads/2016/12/armonsharei.jpghttps://timmermanreport.com/2016/12/13-young-people-bucking-odds-finding-paths-break-biotech/hannahchang-2/2016-12-08T20:02:16+00:00https://timmermanreport.com/wp-content/uploads/2016/12/hannahchang.jpghttps://timmermanreport.com/2016/12/13-young-people-bucking-odds-finding-paths-break-biotech/sebastiankraves/2016-12-08T20:02:49+00:00https://timmermanreport.com/wp-content/uploads/2016/12/sebastiankraves.jpghttps://timmermanreport.com/2016/12/13-young-people-bucking-odds-finding-paths-break-biotech/anasuyamandal/2016-12-08T20:03:11+00:00https://timmermanreport.com/wp-content/uploads/2016/12/AnasuyaMandal.jpghttps://timmermanreport.com/2016/12/trump-vows-drug-price-clampdown-wackadoodle-fda-boss-alzheimers-heat/andypostelection/2016-12-09T19:22:38+00:00https://timmermanreport.com/wp-content/uploads/2016/12/andypostelection.pnghttps://timmermanreport.com/2016/12/trump-vows-drug-price-clampdown-wackadoodle-fda-boss-alzheimers-heat/oneill/2016-12-09T19:35:30+00:00https://timmermanreport.com/wp-content/uploads/2016/12/oneill.pnghttps://timmermanreport.com/2016/12/merck-thumps-gilead-court-genentechs-new-ceo-alexion-turmoil/fdagrainger/2016-12-16T02:29:29+00:00https://timmermanreport.com/wp-content/uploads/2016/12/fdagrainger.pnghttps://timmermanreport.com/2016/12/merck-thumps-gilead-court-genentechs-new-ceo-alexion-turmoil/fda2016/2016-12-16T02:30:37+00:00https://timmermanreport.com/wp-content/uploads/2016/12/fda2016.jpghttps://timmermanreport.com/2016/12/merck-thumps-gilead-court-genentechs-new-ceo-alexion-turmoil/approvals/2016-12-16T02:31:52+00:00https://timmermanreport.com/wp-content/uploads/2016/12/approvals.jpghttps://timmermanreport.com/2016/12/merck-thumps-gilead-court-genentechs-new-ceo-alexion-turmoil/mdanderson/2016-12-16T02:33:04+00:00https://timmermanreport.com/wp-content/uploads/2016/12/mdanderson.pnghttps://timmermanreport.com/2016/12/merck-thumps-gilead-court-genentechs-new-ceo-alexion-turmoil/opht/2016-12-16T02:34:07+00:00https://timmermanreport.com/wp-content/uploads/2016/12/opht.pnghttps://timmermanreport.com/2016/12/merck-thumps-gilead-court-genentechs-new-ceo-alexion-turmoil/sid/2016-12-16T02:34:51+00:00https://timmermanreport.com/wp-content/uploads/2016/12/sid.pnghttps://timmermanreport.com/2016/12/merck-thumps-gilead-court-genentechs-new-ceo-alexion-turmoil/leecooper/2016-12-16T02:35:34+00:00https://timmermanreport.com/wp-content/uploads/2016/12/leecooper.pnghttps://timmermanreport.com/2016/12/merck-thumps-gilead-court-genentechs-new-ceo-alexion-turmoil/sidforbes/2016-12-16T02:41:59+00:00https://timmermanreport.com/wp-content/uploads/2016/12/sidforbes.jpghttps://timmermanreport.com/2016/12/merck-thumps-gilead-court-genentechs-new-ceo-alexion-turmoil/americandream/2016-12-16T02:45:29+00:00https://timmermanreport.com/wp-content/uploads/2016/12/americandream.pnghttps://timmermanreport.com/2016/12/unfashionable-science-daring-model-alzheimers-without-vcs/johnalam/2016-12-21T23:45:42+00:00https://timmermanreport.com/wp-content/uploads/2016/12/johnalam.pnghttps://timmermanreport.com/2016/12/senators-dial-heat-overblown-crispr-case-biogens-new-ceo/hank/2016-12-22T23:48:22+00:00https://timmermanreport.com/wp-content/uploads/2016/12/hank.pnghttps://timmermanreport.com/2016/12/senators-dial-heat-overblown-crispr-case-biogens-new-ceo/denali/2016-12-23T00:05:13+00:00https://timmermanreport.com/wp-content/uploads/2016/12/denali.jpghttps://timmermanreport.com/2016/12/big-rna-day-spinraza-cempra-stumbles-intarcia-rakes-loot/cnbc12282016/2016-12-29T20:30:12+00:00https://timmermanreport.com/wp-content/uploads/2016/12/cnbc12282016.pnghttps://timmermanreport.com/2016/12/big-rna-day-spinraza-cempra-stumbles-intarcia-rakes-loot/burkenusi/2016-12-29T20:40:49+00:00https://timmermanreport.com/wp-content/uploads/2016/12/burkenusi.pnghttps://timmermanreport.com/2017/01/neon-therapeutics-gets-70m-push-neoantigen-cancer-vaccines/hughodowd/2017-01-05T04:20:03+00:00https://timmermanreport.com/wp-content/uploads/2017/01/hughodowd.jpghttps://timmermanreport.com/2017/01/amgen-wins-pcsk9-duel-jenkins-parting-shot-obamacares-last-stand/alexion/2017-01-06T01:19:40+00:00https://timmermanreport.com/wp-content/uploads/2017/01/alexion.pnghttps://timmermanreport.com/2017/01/amgen-wins-pcsk9-duel-jenkins-parting-shot-obamacares-last-stand/amgen/2017-01-06T01:20:49+00:00https://timmermanreport.com/wp-content/uploads/2017/01/amgen.pnghttps://timmermanreport.com/2017/01/amgen-wins-pcsk9-duel-jenkins-parting-shot-obamacares-last-stand/sherkow1/2017-01-06T02:02:00+00:00https://timmermanreport.com/wp-content/uploads/2017/01/sherkow1.jpghttps://timmermanreport.com/2017/01/takeda-takes-ariad-illumina-plants-100-genome-stake-anti-vaxxer-nuzzles-trump/mental/2017-01-13T19:41:05+00:00https://timmermanreport.com/wp-content/uploads/2017/01/mental.pnghttps://timmermanreport.com/2017/01/takeda-takes-ariad-illumina-plants-100-genome-stake-anti-vaxxer-nuzzles-trump/celgprices/2017-01-13T19:41:49+00:00https://timmermanreport.com/wp-content/uploads/2017/01/celgprices.pnghttps://timmermanreport.com/2017/01/takes-two-universities-industry-can-work-together-fix-phd-job-market/boaz-vilozny\_headshot\_w500p/2017-01-17T18:09:03+00:00https://timmermanreport.com/wp-content/uploads/2017/01/Boaz-Vilozny\_Headshot\_w500p.pnghttps://timmermanreport.com/2017/01/whos-trumps-health-team-bms-cedes-ground-merck-cre-superbugs-move/humiraprice/2017-01-20T03:53:12+00:00https://timmermanreport.com/wp-content/uploads/2017/01/humiraprice.pnghttps://timmermanreport.com/2017/01/whos-trumps-health-team-bms-cedes-ground-merck-cre-superbugs-move/funds/2017-01-20T04:02:13+00:00https://timmermanreport.com/wp-content/uploads/2017/01/funds.pnghttps://timmermanreport.com/2017/01/whos-trumps-health-team-bms-cedes-ground-merck-cre-superbugs-move/vyastweet/2017-01-20T04:48:43+00:00https://timmermanreport.com/wp-content/uploads/2017/01/vyastweet.pnghttps://timmermanreport.com/2017/02/now-ever-need-personalized-medicine-immuno-oncology/ac-headshot/2017-01-20T17:54:55+00:00https://timmermanreport.com/wp-content/uploads/2017/01/AC-Headshot.jpghttps://timmermanreport.com/2017/02/canadian-biotech-breakaway/canadavc/2017-01-22T03:59:10+00:00https://timmermanreport.com/wp-content/uploads/2017/01/canadavc.pnghttps://timmermanreport.com/2017/02/hiring-women-execs-biotech-vc-firms-moneyball-play-part-1-getting-better-returns/frangraphs/2017-01-22T23:17:59+00:00https://timmermanreport.com/wp-content/uploads/2017/01/frangraphs.pnghttps://timmermanreport.com/2017/02/hiring-women-execs-biotech-vc-firms-moneyball-play-part-1-getting-better-returns/femalefounders/2017-01-22T23:18:33+00:00https://timmermanreport.com/wp-content/uploads/2017/01/femalefounders.pnghttps://timmermanreport.com/2017/01/women-making-progress-slowly-biotech-boards-report-says/fig3/2017-01-23T22:30:13+00:00https://timmermanreport.com/wp-content/uploads/2017/01/fig3.pnghttps://timmermanreport.com/2017/01/drug-delivery-devices-tantalize-promise-adherence-local-delivery-personalization/stacyl/2017-01-23T23:15:54+00:00https://timmermanreport.com/wp-content/uploads/2017/01/stacyl.pnghttps://timmermanreport.com/2017/01/drug-delivery-devices-tantalize-promise-adherence-local-delivery-personalization/kurtgraves/2017-01-23T23:49:02+00:00https://timmermanreport.com/wp-content/uploads/2017/01/kurtgraves.jpghttps://timmermanreport.com/about-luke-timmerman/ltsfanniversary/2017-01-24T04:01:59+00:00https://timmermanreport.com/wp-content/uploads/2014/12/ltsfanniversary.jpghttps://timmermanreport.com/events/bts\_17-870-1/2017-01-24T04:05:03+00:00https://timmermanreport.com/wp-content/uploads/2014/12/BTS\_17-870-1.jpghttps://timmermanreport.com/2017/02/pulse-check-patient-centricity-7-vital-signs/kim-mccleary/2017-01-25T19:29:39+00:00https://timmermanreport.com/wp-content/uploads/2017/02/Kim-McCleary.jpghttps://timmermanreport.com/2017/01/jj-reels-actelion-30b-celgene-snaps-delinia-ipo-flurry/gorsky/2017-01-27T19:51:43+00:00https://timmermanreport.com/wp-content/uploads/2017/01/gorsky.pnghttps://timmermanreport.com/2017/01/jj-reels-actelion-30b-celgene-snaps-delinia-ipo-flurry/megjj/2017-01-27T19:53:40+00:00https://timmermanreport.com/wp-content/uploads/2017/01/megjj.pnghttps://timmermanreport.com/2017/01/jj-reels-actelion-30b-celgene-snaps-delinia-ipo-flurry/biohack/2017-01-27T19:56:00+00:00https://timmermanreport.com/wp-content/uploads/2017/01/biohack.pnghttps://timmermanreport.com/2017/01/jj-reels-actelion-30b-celgene-snaps-delinia-ipo-flurry/skorney/2017-01-27T19:58:28+00:00https://timmermanreport.com/wp-content/uploads/2017/01/skorney.pnghttps://timmermanreport.com/2017/02/road-not-traveled-journey-phd-biotech-business-finance-industry/lukelee-page/2017-01-27T20:49:33+00:00https://timmermanreport.com/wp-content/uploads/2017/01/lukelee-page.jpghttps://timmermanreport.com/2017/02/join-bio-europe-spring-mar-21-barcelona-talk-eu-entrepreneurship/mayweg/2017-01-27T23:02:06+00:00https://timmermanreport.com/wp-content/uploads/2017/01/mayweg.jpghttps://timmermanreport.com/2017/02/bms-block-maybe-sarepta-sells-golden-ticket-gilead-summit-pic/teamsummit/2017-02-23T22:21:39+00:00https://timmermanreport.com/wp-content/uploads/2017/02/teamsummit.jpghttps://timmermanreport.com/2017/02/bms-block-maybe-sarepta-sells-golden-ticket-gilead-summit-pic/houston/2017-02-23T22:25:44+00:00https://timmermanreport.com/wp-content/uploads/2017/02/houston.jpghttps://timmermanreport.com/2017/02/bms-block-maybe-sarepta-sells-golden-ticket-gilead-summit-pic/bijanjuno/2017-02-23T22:36:47+00:00https://timmermanreport.com/wp-content/uploads/2017/02/bijanjuno.pnghttps://timmermanreport.com/2017/02/bms-block-maybe-sarepta-sells-golden-ticket-gilead-summit-pic/frazier/2017-02-23T22:38:39+00:00https://timmermanreport.com/wp-content/uploads/2017/02/frazier.pnghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1328/2017-02-25T18:57:20+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1328.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1342/2017-02-25T18:57:29+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1342.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1356/2017-02-25T18:57:40+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1356.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1362/2017-02-25T18:57:49+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1362.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1372/2017-02-25T18:57:58+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1372.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1380/2017-02-25T18:58:09+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1380.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1383/2017-02-25T18:58:19+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1383.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1444/2017-02-25T18:58:29+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1444.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1449/2017-02-25T18:58:40+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1449.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1451/2017-02-25T18:58:49+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1451.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1633/2017-02-25T18:58:59+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1633.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2249/2017-02-25T18:59:10+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2249.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2254/2017-02-25T18:59:19+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2254.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2262/2017-02-25T18:59:30+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2262.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2280/2017-02-25T18:59:39+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2280.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2290/2017-02-25T18:59:50+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2290.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2291/2017-02-25T18:59:59+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2291.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2338/2017-02-25T19:00:12+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2338.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2339/2017-02-25T19:00:22+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2339.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2349/2017-02-25T19:00:32+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2349.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2362/2017-02-25T19:00:42+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2362.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2364/2017-02-25T19:00:50+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2364.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2365/2017-02-25T19:01:00+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2365.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2371/2017-02-25T19:01:09+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2371.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2380/2017-02-25T19:01:19+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2380.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2382/2017-02-25T19:01:28+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2382.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2383/2017-02-25T19:01:37+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2383.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2384/2017-02-25T19:01:47+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2384.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2385/2017-02-25T19:01:57+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2385.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2396/2017-02-25T19:02:06+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2396.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2412/2017-02-25T19:02:15+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2412-e1488049629488.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_5773/2017-02-25T19:02:27+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_5773.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/teamsummit-2/2017-02-25T19:02:34+00:00https://timmermanreport.com/wp-content/uploads/2017/02/teamsummit-1.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1198/2017-02-25T19:02:50+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1198.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1206/2017-02-25T19:03:00+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1206.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1234/2017-02-25T19:03:11+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1234.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1251/2017-02-25T19:03:22+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1251.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1260/2017-02-25T19:03:31+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1260.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1269/2017-02-25T19:03:38+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1269.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1276/2017-02-25T19:03:43+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1276.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1290/2017-02-25T19:03:52+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1290.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1309/2017-02-25T19:04:01+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1309.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1323/2017-02-25T19:04:11+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1323.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_1177/2017-02-25T19:14:12+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_1177.jpghttps://timmermanreport.com/2017/02/aconcagua-expedition-photos/img\_2314-copy/2017-02-25T23:13:46+00:00https://timmermanreport.com/wp-content/uploads/2017/02/IMG\_2314-Copy.jpghttps://timmermanreport.com/2016/02/are-you-ready-for-some-football-maybe-yes-maybe-no/lisasuennen/2017-03-09T20:41:48+00:00https://timmermanreport.com/wp-content/uploads/2016/02/lisasuennen.jpghttps://timmermanreport.com/2017/03/gottlieb-deck-fda-editing-human-embryos-gilead-exec-rips-pbms/kliff/2017-03-10T19:38:38+00:00https://timmermanreport.com/wp-content/uploads/2017/03/kliff.jpghttps://timmermanreport.com/2017/03/gottlieb-deck-fda-editing-human-embryos-gilead-exec-rips-pbms/mediascience/2017-03-10T19:43:22+00:00https://timmermanreport.com/wp-content/uploads/2017/03/mediascience.pnghttps://timmermanreport.com/2017/03/gottlieb-deck-fda-editing-human-embryos-gilead-exec-rips-pbms/bolle/2017-03-10T19:53:43+00:00https://timmermanreport.com/wp-content/uploads/2017/03/bolle.pnghttps://timmermanreport.com/2017/03/egenesis-snags-38m-make-crispr-modified-pigs-organ-transplantation/luhanyang/2017-03-15T23:04:15+00:00https://timmermanreport.com/wp-content/uploads/2017/03/luhanyang.pnghttps://timmermanreport.com/2017/03/white-house-wants-whack-nih-allergans-crispr-foray-new-vcs-sprout/phrmastatement/2017-03-16T23:06:35+00:00https://timmermanreport.com/wp-content/uploads/2017/03/phrmastatement.pnghttps://timmermanreport.com/2017/03/opioid-crisis-needs-help-biotech-nektar-drug-half-step/nktrsummit/2017-03-18T18:39:16+00:00https://timmermanreport.com/wp-content/uploads/2017/03/nktrsummit.pnghttps://timmermanreport.com/2017/03/opioid-crisis-needs-help-biotech-nektar-drug-half-step/steve\_doberstein\_c8w0101-2/2017-03-18T18:46:28+00:00https://timmermanreport.com/wp-content/uploads/2017/03/Steve\_Doberstein\_C8W0101-2.jpghttps://timmermanreport.com/2017/03/amgens-pcsk9-mixed-bag-regeneron-gsks-genomics-bet-healthcare-vote-stalls/begleytweet/2017-03-24T01:37:46+00:00https://timmermanreport.com/wp-content/uploads/2017/03/begleytweet.pnghttps://timmermanreport.com/2017/03/amgens-pcsk9-mixed-bag-regeneron-gsks-genomics-bet-healthcare-vote-stalls/califftweet/2017-03-24T01:53:20+00:00https://timmermanreport.com/wp-content/uploads/2017/03/califftweet.pnghttps://timmermanreport.com/2017/03/dont-miss-tr-anniversary-parties-boston-seattle/trlaunchboston2015/2017-03-24T17:27:36+00:00https://timmermanreport.com/wp-content/uploads/2017/03/TRlaunchBoston2015.jpghttps://timmermanreport.com/2017/03/dont-miss-tr-anniversary-parties-boston-seattle/trseattlelauchphoto/2017-03-24T17:31:06+00:00https://timmermanreport.com/wp-content/uploads/2017/03/TRseattleLauchPhoto.jpghttps://timmermanreport.com/2017/03/third-rocks-tango-gets-55m-crispr-enabled-synthetic-lethal-cancer-combos/bweber/2017-03-30T00:11:13+00:00https://timmermanreport.com/wp-content/uploads/2017/03/bweber.jpghttps://timmermanreport.com/2017/04/six-clues-show-academic-institution-serious-entrepreneurship/issirozen/2017-04-02T00:06:46+00:00https://timmermanreport.com/wp-content/uploads/2017/04/IssiRozen.jpghttps://timmermanreport.com/2017/04/allens-100m-cell-biology-resource-cool-idea-long-way-go-scientists-say/rickhorwitz\_web\_bg-2-jpg\_\_148x148\_q85\_crop\_subsampling-2/2017-04-05T00:40:01+00:00https://timmermanreport.com/wp-content/uploads/2017/04/rickhorwitz\_web\_bg-2.jpg\_\_148x148\_q85\_crop\_subsampling-2.pnghttps://timmermanreport.com/2017/04/aacr-reflections-genomics-adapts-o-world-scientists-stand-re-thinking-fight-early-stage-cancer/samtweet1/2017-04-06T19:02:32+00:00https://timmermanreport.com/wp-content/uploads/2017/04/samtweet1.pnghttps://timmermanreport.com/2017/04/aacr-reflections-genomics-adapts-o-world-scientists-stand-re-thinking-fight-early-stage-cancer/samtweet2/2017-04-06T19:03:25+00:00https://timmermanreport.com/wp-content/uploads/2017/04/samtweet2.pnghttps://timmermanreport.com/2017/04/aacr-reflections-genomics-adapts-o-world-scientists-stand-re-thinking-fight-early-stage-cancer/samtweet3/2017-04-06T19:03:56+00:00https://timmermanreport.com/wp-content/uploads/2017/04/samtweet3.pnghttps://timmermanreport.com/2017/04/aacr-reflections-genomics-adapts-o-world-scientists-stand-re-thinking-fight-early-stage-cancer/samtweet4/2017-04-06T19:04:18+00:00https://timmermanreport.com/wp-content/uploads/2017/04/samtweet4.pnghttps://timmermanreport.com/2017/04/aacr-reflections-genomics-adapts-o-world-scientists-stand-re-thinking-fight-early-stage-cancer/samtweet5/2017-04-06T19:05:11+00:00https://timmermanreport.com/wp-content/uploads/2017/04/samtweet5.pnghttps://timmermanreport.com/2017/04/aacr-reflections-genomics-adapts-o-world-scientists-stand-re-thinking-fight-early-stage-cancer/samtweet6/2017-04-06T19:05:43+00:00https://timmermanreport.com/wp-content/uploads/2017/04/samtweet6.pnghttps://timmermanreport.com/2017/04/aacr-reflections-genomics-adapts-o-world-scientists-stand-re-thinking-fight-early-stage-cancer/blackman\_samuel/2017-04-06T19:07:54+00:00https://timmermanreport.com/wp-content/uploads/2017/04/sblackman.jpghttps://timmermanreport.com/2017/04/gottlieb-nails-senate-hearing-23andme-back-fdas-good-grace-aacr-reflections/karlin-smith/2017-04-07T04:08:14+00:00https://timmermanreport.com/wp-content/uploads/2017/04/karlin-smith.pnghttps://timmermanreport.com/2017/04/gottlieb-nails-senate-hearing-23andme-back-fdas-good-grace-aacr-reflections/rattner/2017-04-07T04:08:42+00:00https://timmermanreport.com/wp-content/uploads/2017/04/rattner.pnghttps://timmermanreport.com/2017/04/boston-biotech-see-tr-anniversary-party-thursday-afternoon/dsc\_0396-2/2017-04-10T19:03:00+00:00https://timmermanreport.com/wp-content/uploads/2017/04/DSC\_0396.jpghttps://timmermanreport.com/2017/04/sec-busts-paid-stock-pumpers-neurocrine-scores-fda-ok-bms-unloads-two-assets/shaywitztweet/2017-04-14T13:20:28+00:00https://timmermanreport.com/wp-content/uploads/2017/04/shaywitztweet.pnghttps://timmermanreport.com/2017/04/photos-tr-anniversary-party-boston-marathon/dsc\_0081/2017-04-19T18:10:01+00:00https://timmermanreport.com/wp-content/uploads/2017/04/DSC\_0081.jpghttps://timmermanreport.com/2017/04/photos-tr-anniversary-party-boston-marathon/dsc\_0055/2017-04-19T18:12:24+00:00https://timmermanreport.com/wp-content/uploads/2017/04/DSC\_0055.jpghttps://timmermanreport.com/2017/04/photos-tr-anniversary-party-boston-marathon/dsc\_0084/2017-04-19T18:19:19+00:00https://timmermanreport.com/wp-content/uploads/2017/04/DSC\_0084.jpghttps://timmermanreport.com/2017/04/photos-tr-anniversary-party-boston-marathon/dsc\_0099/2017-04-19T18:22:45+00:00https://timmermanreport.com/wp-content/uploads/2017/04/DSC\_0099.jpghttps://timmermanreport.com/2017/04/photos-tr-anniversary-party-boston-marathon/wp\_20170413\_16\_54\_55\_pro/2017-04-19T18:24:37+00:00https://timmermanreport.com/wp-content/uploads/2017/04/WP\_20170413\_16\_54\_55\_Pro.jpghttps://timmermanreport.com/2017/04/photos-tr-anniversary-party-boston-marathon/wp\_20170413\_16\_42\_04\_pro/2017-04-19T18:26:13+00:00https://timmermanreport.com/wp-content/uploads/2017/04/WP\_20170413\_16\_42\_04\_Pro.jpghttps://timmermanreport.com/2017/04/photos-tr-anniversary-party-boston-marathon/wp\_20170413\_17\_59\_32\_pro/2017-04-19T18:28:41+00:00https://timmermanreport.com/wp-content/uploads/2017/04/WP\_20170413\_17\_59\_32\_Pro.jpghttps://timmermanreport.com/2017/04/photos-tr-anniversary-party-boston-marathon/wp\_20170413\_18\_00\_41\_pro/2017-04-19T18:31:33+00:00https://timmermanreport.com/wp-content/uploads/2017/04/WP\_20170413\_18\_00\_41\_Pro.jpghttps://timmermanreport.com/2017/04/photos-tr-anniversary-party-boston-marathon/wp\_20170415\_007/2017-04-19T18:33:41+00:00https://timmermanreport.com/wp-content/uploads/2017/04/WP\_20170415\_007.jpghttps://timmermanreport.com/2017/04/photos-tr-anniversary-party-boston-marathon/bostonmarathon2017fullsize/2017-04-19T18:37:36+00:00https://timmermanreport.com/wp-content/uploads/2017/04/BostonMarathon2017fullsize.jpghttps://timmermanreport.com/2017/04/photos-tr-anniversary-party-boston-marathon/dsc\_0081-2/2017-04-19T18:47:58+00:00https://timmermanreport.com/wp-content/uploads/2017/04/DSC\_0081-1.jpghttps://timmermanreport.com/2017/04/photos-tr-anniversary-party-boston-marathon/dsc\_0100/2017-04-19T19:27:34+00:00https://timmermanreport.com/wp-content/uploads/2017/04/DSC\_0100.jpghttps://timmermanreport.com/2017/04/photos-tr-anniversary-party-boston-marathon/wp\_20170413\_16\_45\_50\_pro/2017-04-19T19:32:57+00:00https://timmermanreport.com/wp-content/uploads/2017/04/WP\_20170413\_16\_45\_50\_Pro.jpghttps://timmermanreport.com/2017/04/verily-verily-everywhere-tesaros-cheaper-parp-not-really-juno-exec-shakeup/sektweet/2017-04-20T21:40:43+00:00https://timmermanreport.com/wp-content/uploads/2017/04/sektweet.pnghttps://timmermanreport.com/2017/04/verily-verily-everywhere-tesaros-cheaper-parp-not-really-juno-exec-shakeup/andyzejula/2017-04-20T21:42:19+00:00https://timmermanreport.com/wp-content/uploads/2017/04/andyzejula.pnghttps://timmermanreport.com/2017/04/foreword-hood-trailblazer-genomics-age-david-baltimore/baltimore-1/2017-04-21T17:17:29+00:00https://timmermanreport.com/wp-content/uploads/2017/04/Baltimore-1.jpghttps://timmermanreport.com/2017/04/foreword-hood-trailblazer-genomics-age-david-baltimore/hood\_enhanced\_cover-2/2017-04-21T20:31:20+00:00https://timmermanreport.com/wp-content/uploads/2017/04/Hood\_Enhanced\_Cover-2.pnghttps://timmermanreport.com/2017/04/foreword-hood-trailblazer-genomics-age-david-baltimore/librologo/2017-04-21T20:47:06+00:00https://timmermanreport.com/wp-content/uploads/2017/04/librologo.jpghttps://timmermanreport.com/2017/04/foreword-hood-trailblazer-genomics-age-david-baltimore/hoodscreenshot/2017-04-23T16:19:18+00:00https://timmermanreport.com/wp-content/uploads/2017/04/hoodscreenshot.jpghttps://timmermanreport.com/2017/04/biotech-execs-going-white-house-nash-buzz-zuckerberg-bankrolls-preprint-movement/hopkins/2017-04-27T21:56:22+00:00https://timmermanreport.com/wp-content/uploads/2017/04/hopkins.pnghttps://timmermanreport.com/2017/04/biotech-execs-going-white-house-nash-buzz-zuckerberg-bankrolls-preprint-movement/cohennbc/2017-04-27T22:13:23+00:00https://timmermanreport.com/wp-content/uploads/2017/04/cohennbc.pnghttps://timmermanreport.com/2017/04/biotech-execs-going-white-house-nash-buzz-zuckerberg-bankrolls-preprint-movement/leonid/2017-04-27T22:14:09+00:00https://timmermanreport.com/wp-content/uploads/2017/04/leonid.pnghttps://timmermanreport.com/2017/04/biotech-execs-going-white-house-nash-buzz-zuckerberg-bankrolls-preprint-movement/cong/2017-04-27T22:15:35+00:00https://timmermanreport.com/wp-content/uploads/2017/04/cong.pnghttps://timmermanreport.com/2017/05/whos-long-read-linked-read-dna-sequencing/shendure/2017-04-30T17:41:08+00:00https://timmermanreport.com/wp-content/uploads/2017/04/shendure.jpghttps://timmermanreport.com/events/milkenglobal2017/2017-05-03T02:22:48+00:00https://timmermanreport.com/wp-content/uploads/2014/12/milkenglobal2017.jpghttps://timmermanreport.com/2017/05/house-passes-trumpcare-alzheimers-drug-shenanigans-ipo-flurry/rockoffphrma/2017-05-05T00:18:47+00:00https://timmermanreport.com/wp-content/uploads/2017/05/rockoffphrma.pnghttps://timmermanreport.com/2017/05/house-passes-trumpcare-alzheimers-drug-shenanigans-ipo-flurry/cummings/2017-05-05T00:19:19+00:00https://timmermanreport.com/wp-content/uploads/2017/05/cummings.pnghttps://timmermanreport.com/2017/05/house-passes-trumpcare-alzheimers-drug-shenanigans-ipo-flurry/process/2017-05-05T00:22:15+00:00https://timmermanreport.com/wp-content/uploads/2017/05/process.pnghttps://timmermanreport.com/2017/05/house-passes-trumpcare-alzheimers-drug-shenanigans-ipo-flurry/simpsons/2017-05-05T00:24:46+00:00https://timmermanreport.com/wp-content/uploads/2017/05/simpsons.pnghttps://timmermanreport.com/2017/05/house-passes-trumpcare-alzheimers-drug-shenanigans-ipo-flurry/milkenglobal2017-2/2017-05-05T03:36:55+00:00https://timmermanreport.com/wp-content/uploads/2017/05/milkenglobal2017-e1494092181747.jpghttps://timmermanreport.com/2017/05/palpitations-pd-1pd-l1-land-mystery-als-drug-approval-car-t-scare/physicianstweet/2017-05-12T02:24:01+00:00https://timmermanreport.com/wp-content/uploads/2017/05/physicianstweet.pnghttps://timmermanreport.com/2017/05/palpitations-pd-1pd-l1-land-mystery-als-drug-approval-car-t-scare/gottliebtweet/2017-05-12T02:49:38+00:00https://timmermanreport.com/wp-content/uploads/2017/05/gottliebtweet.pnghttps://timmermanreport.com/2017/05/biotech-people-care-can-industry-make-difference/robperez/2017-05-15T19:25:33+00:00https://timmermanreport.com/wp-content/uploads/2017/05/robperez.jpghttps://timmermanreport.com/2017/05/biotech-people-care-can-industry-make-difference/sarahmacdonald/2017-05-15T19:26:56+00:00https://timmermanreport.com/wp-content/uploads/2017/05/sarahmacdonald.jpghttps://timmermanreport.com/2017/05/former-lieutenants-tribute-henri-termeer/chris\_rivera\_headshot\_resized/2017-05-17T20:51:37+00:00https://timmermanreport.com/wp-content/uploads/2017/05/chris\_rivera\_headshot\_resized.jpghttps://timmermanreport.com/2017/05/former-sarepta-ceo-gets-15m-hedge-fund-startup-incubator/cgarabedian/2017-05-18T00:43:26+00:00https://timmermanreport.com/wp-content/uploads/2017/05/cgarabedian.jpghttps://timmermanreport.com/readers-saying/anasuyaheadshot/2017-05-19T02:25:24+00:00https://timmermanreport.com/wp-content/uploads/2015/01/anasuyaheadshot.jpghttps://timmermanreport.com/readers-saying/anasuyamit/2017-05-19T02:26:52+00:00https://timmermanreport.com/wp-content/uploads/2015/01/anasuyaMIT.jpghttps://timmermanreport.com/2017/05/biotech-pioneer-leaves-us-verily-hires-ex-fda-commish-amazon-prowling-pharma/termeertweet/2017-05-19T03:45:25+00:00https://timmermanreport.com/wp-content/uploads/2017/05/termeertweet.pnghttps://timmermanreport.com/2017/05/12-vcs-matter-never-read-2/garheng/2017-05-24T23:27:57+00:00https://timmermanreport.com/wp-content/uploads/2017/05/garheng.jpghttps://timmermanreport.com/2017/05/12-vcs-matter-never-read-2/jeangeorge/2017-05-24T23:39:15+00:00https://timmermanreport.com/wp-content/uploads/2017/05/JeanGeorge.jpghttps://timmermanreport.com/2017/05/alexion-expose-historic-first-fda-pumas-come-behind-victory/suetweet-2/2017-05-25T23:55:18+00:00https://timmermanreport.com/wp-content/uploads/2017/05/suetweet.pnghttps://timmermanreport.com/2017/05/alexion-expose-historic-first-fda-pumas-come-behind-victory/popsgottlieb/2017-05-26T00:00:35+00:00https://timmermanreport.com/wp-content/uploads/2017/05/popsgottlieb.pnghttps://timmermanreport.com/2017/05/alexion-expose-historic-first-fda-pumas-come-behind-victory/pumachart/2017-05-26T14:29:16+00:00https://timmermanreport.com/wp-content/uploads/2017/05/pumachart.pnghttps://timmermanreport.com/2017/06/atlas-venture-lures-rising-star-kevin-bitterman-away-polaris/bittermanmug/2017-05-31T23:38:03+00:00https://timmermanreport.com/wp-content/uploads/2017/05/bittermanmug.jpghttps://timmermanreport.com/2017/06/state-ags-pull-knives-pharma-grail-grows-acquisition-crispr-jitters/tsro/2017-06-02T16:54:54+00:00https://timmermanreport.com/wp-content/uploads/2017/06/tsro.pnghttps://timmermanreport.com/2017/06/state-ags-pull-knives-pharma-grail-grows-acquisition-crispr-jitters/adhd/2017-06-02T16:56:24+00:00https://timmermanreport.com/wp-content/uploads/2017/06/adhd.pnghttps://timmermanreport.com/2017/06/state-ags-pull-knives-pharma-grail-grows-acquisition-crispr-jitters/crisprjitters/2017-06-02T17:03:38+00:00https://timmermanreport.com/wp-content/uploads/2017/06/crisprjitters.pnghttps://timmermanreport.com/2017/06/asco-notebook-observations-cancer-rd-foundation-medicine-halozyme-blueprint-nektar/troycox/2017-06-05T02:06:00+00:00https://timmermanreport.com/wp-content/uploads/2017/06/troycox.jpghttps://timmermanreport.com/2017/06/asco-notebook-observations-cancer-rd-foundation-medicine-halozyme-blueprint-nektar/jonathanz/2017-06-05T02:09:00+00:00https://timmermanreport.com/wp-content/uploads/2017/06/jonathanz.jpghttps://timmermanreport.com/2017/06/asco-takeaways-z-part-1/incyloncar1/2017-06-08T00:52:38+00:00https://timmermanreport.com/wp-content/uploads/2017/06/incyloncar1.pnghttps://timmermanreport.com/2017/06/asco-takeaways-z-part-1/loncarmellman/2017-06-08T00:53:26+00:00https://timmermanreport.com/wp-content/uploads/2017/06/loncarmellman.pnghttps://timmermanreport.com/2017/06/asco-takeaways-z-part-1/incystock/2017-06-08T00:53:58+00:00https://timmermanreport.com/wp-content/uploads/2017/06/incystock.pnghttps://timmermanreport.com/2017/06/asco-takeaways-z-part-1/gskkeiper/2017-06-08T00:56:01+00:00https://timmermanreport.com/wp-content/uploads/2017/06/gskkeiper.pnghttps://timmermanreport.com/2017/06/asco-takeaways-z-part-1/bluesafety/2017-06-08T01:01:44+00:00https://timmermanreport.com/wp-content/uploads/2017/06/bluesafety.pnghttps://timmermanreport.com/2017/06/asco-takeaways-z-part-1/socialcitizen/2017-06-08T01:03:07+00:00https://timmermanreport.com/wp-content/uploads/2017/06/socialcitizen.pnghttps://timmermanreport.com/2017/06/asco-takeaways-z-part-2/loxochart/2017-06-08T20:46:50+00:00https://timmermanreport.com/wp-content/uploads/2017/06/loxochart.pnghttps://timmermanreport.com/2017/06/asco-takeaways-z-part-2/baselga/2017-06-08T20:59:49+00:00https://timmermanreport.com/wp-content/uploads/2017/06/baselga.jpghttps://timmermanreport.com/2017/06/asco-takeaways-z-part-2/westalex/2017-06-08T21:01:04+00:00https://timmermanreport.com/wp-content/uploads/2017/06/westalex.pnghttps://timmermanreport.com/2017/06/fda-drops-opioid-hammer-collins-stays-nih-pfizers-relentless-ratcheting/collinsrenew/2017-06-09T03:26:47+00:00https://timmermanreport.com/wp-content/uploads/2017/06/collinsrenew.pnghttps://timmermanreport.com/2017/06/fda-drops-opioid-hammer-collins-stays-nih-pfizers-relentless-ratcheting/umerjazz/2017-06-09T03:28:52+00:00https://timmermanreport.com/wp-content/uploads/2017/06/umerjazz.pnghttps://timmermanreport.com/2017/06/long-distance-relationships-biotech-startups-make-work/eriklundh/2017-06-09T23:30:15+00:00https://timmermanreport.com/wp-content/uploads/2017/06/eriklundh.jpeghttps://timmermanreport.com/2017/06/long-distance-relationships-biotech-startups-make-work/aallen/2017-06-09T23:32:33+00:00https://timmermanreport.com/wp-content/uploads/2017/06/aallen.jpghttps://timmermanreport.com/2017/06/dos-donts-startup-boards/bobmore-2/2017-06-14T21:41:09+00:00https://timmermanreport.com/wp-content/uploads/2017/06/bobmore-e1497476431914.jpghttps://timmermanreport.com/2017/06/supreme-court-speeds-biosimilars-clancys-lucrative-switch-apple-sniffs-around-health-records/darkweb/2017-06-16T21:50:29+00:00https://timmermanreport.com/wp-content/uploads/2017/06/darkweb.pnghttps://timmermanreport.com/2017/06/supreme-court-speeds-biosimilars-clancys-lucrative-switch-apple-sniffs-around-health-records/tesarofiveday/2017-06-16T21:51:52+00:00https://timmermanreport.com/wp-content/uploads/2017/06/tesarofiveday.pnghttps://timmermanreport.com/2017/06/supreme-court-speeds-biosimilars-clancys-lucrative-switch-apple-sniffs-around-health-records/granttweet/2017-06-16T21:54:29+00:00https://timmermanreport.com/wp-content/uploads/2017/06/granttweet.pnghttps://timmermanreport.com/2017/06/supreme-court-speeds-biosimilars-clancys-lucrative-switch-apple-sniffs-around-health-records/gatestweet/2017-06-16T22:05:26+00:00https://timmermanreport.com/wp-content/uploads/2017/06/gatestweet.pnghttps://timmermanreport.com/2017/06/supreme-court-speeds-biosimilars-clancys-lucrative-switch-apple-sniffs-around-health-records/alexionstock/2017-06-16T22:10:00+00:00https://timmermanreport.com/wp-content/uploads/2017/06/alexionstock.jpghttps://timmermanreport.com/2017/06/american-sickness-skillful-deconvolution-u-s-healthcare/americansickness/2017-06-17T19:41:47+00:00https://timmermanreport.com/wp-content/uploads/2017/06/americansickness.jpghttps://timmermanreport.com/2017/06/rubius-snags-120m-engineer-red-blood-cell-therapies-off-shelf/torsten1/2017-06-21T02:23:10+00:00https://timmermanreport.com/wp-content/uploads/2017/06/torsten1.pnghttps://timmermanreport.com/2017/06/repare-secures-68m-series-discover-synthetic-lethal-cancer-drugs/portrait/2017-06-22T00:33:46+00:00https://timmermanreport.com/wp-content/uploads/2017/06/lsegal.jpghttps://timmermanreport.com/hood-book/hoodatneurocrine/2017-06-22T18:45:33+00:00https://timmermanreport.com/wp-content/uploads/2016/08/HoodatNeurocrine.jpghttps://timmermanreport.com/2017/06/secret-senate-healthcare-overhaul-advances-novartis-nails-cv-study-clovis-cashes-parp-win/biostatementsenate/2017-06-23T00:37:50+00:00https://timmermanreport.com/wp-content/uploads/2017/06/biostatementsenate.pnghttps://timmermanreport.com/2017/06/secret-senate-healthcare-overhaul-advances-novartis-nails-cv-study-clovis-cashes-parp-win/schwabnvca/2017-06-23T00:53:47+00:00https://timmermanreport.com/wp-content/uploads/2017/06/schwabnvca.pnghttps://timmermanreport.com/2017/06/secret-senate-healthcare-overhaul-advances-novartis-nails-cv-study-clovis-cashes-parp-win/caroline/2017-06-23T02:18:29+00:00https://timmermanreport.com/wp-content/uploads/2017/06/caroline.jpghttps://timmermanreport.com/hood-book/dnanexustweet/2017-06-23T18:04:03+00:00https://timmermanreport.com/wp-content/uploads/2016/08/dnanexustweet.jpghttps://timmermanreport.com/hood-book/dagrostweet/2017-06-23T18:05:39+00:00https://timmermanreport.com/wp-content/uploads/2016/08/dagrostweet.jpghttps://timmermanreport.com/hood-book/kevinwutweet/2017-06-23T18:07:55+00:00https://timmermanreport.com/wp-content/uploads/2016/08/kevinwutweet.jpghttps://timmermanreport.com/hood-book/illuminabooktweet/2017-06-23T18:25:27+00:00https://timmermanreport.com/wp-content/uploads/2016/08/illuminabooktweet.jpghttps://timmermanreport.com/2017/06/watershed-moments-celgene-bristol-myers-squibb-became-deal-winners/jdm/2017-06-24T01:12:18+00:00https://timmermanreport.com/wp-content/uploads/2017/06/jdm.jpghttps://timmermanreport.com/2017/06/watershed-moments-celgene-bristol-myers-squibb-became-deal-winners/bassil/2017-06-24T01:13:23+00:00https://timmermanreport.com/wp-content/uploads/2017/06/bassil.jpghttps://timmermanreport.com/hood-book/hardcover-new-front/2017-06-27T05:31:09+00:00https://timmermanreport.com/wp-content/uploads/2016/08/hardcover-new-front.jpghttps://timmermanreport.com/2017/06/find-biotech-startup-cash-without-traditional-vcs/briangallagher-3/2017-06-28T19:43:00+00:00https://timmermanreport.com/wp-content/uploads/2017/06/briangallagher.jpghttps://timmermanreport.com/2017/06/mercks-cv-surprise-fda-clamors-generics-amgen-illuminas-precision-medicine-win/sachs/2017-06-29T23:14:34+00:00https://timmermanreport.com/wp-content/uploads/2017/06/sachs.pnghttps://timmermanreport.com/2017/06/mercks-cv-surprise-fda-clamors-generics-amgen-illuminas-precision-medicine-win/datadiarrhea/2017-06-29T23:25:03+00:00https://timmermanreport.com/wp-content/uploads/2017/06/datadiarrhea.pnghttps://timmermanreport.com/2017/06/mercks-cv-surprise-fda-clamors-generics-amgen-illuminas-precision-medicine-win/andycara/2017-06-29T23:25:44+00:00https://timmermanreport.com/wp-content/uploads/2017/06/andycara.pnghttps://timmermanreport.com/2017/06/mercks-cv-surprise-fda-clamors-generics-amgen-illuminas-precision-medicine-win/keytrudatweet/2017-06-29T23:42:09+00:00https://timmermanreport.com/wp-content/uploads/2017/06/keytrudatweet.pnghttps://timmermanreport.com/2017/07/think-drug-best-class-world-changes/nagesh/2017-07-02T22:24:29+00:00https://timmermanreport.com/wp-content/uploads/2017/07/Nagesh.jpghttps://timmermanreport.com/2017/07/single-cloned-microbe-orchestrate-immune-system-evelo-gets-50m-test-concept/krishna-yeshwant/2017-07-10T23:52:08+00:00https://timmermanreport.com/wp-content/uploads/2017/07/krishna-yeshwant.jpghttps://timmermanreport.com/2017/07/single-cloned-microbe-orchestrate-immune-system-evelo-gets-50m-test-concept/simba/2017-07-10T23:54:58+00:00https://timmermanreport.com/wp-content/uploads/2017/07/simba.pnghttps://timmermanreport.com/2017/07/novartis-big-car-t-moment-amicus-exits-fda-penalty-box-evelos-bold-50m-microbiome-play/rtntweets/2017-07-14T00:07:18+00:00https://timmermanreport.com/wp-content/uploads/2017/07/rtntweets.pnghttps://timmermanreport.com/2017/07/novartis-big-car-t-moment-amicus-exits-fda-penalty-box-evelos-bold-50m-microbiome-play/gottliebgenerics/2017-07-14T00:13:25+00:00https://timmermanreport.com/wp-content/uploads/2017/07/gottliebgenerics.pnghttps://timmermanreport.com/2017/07/whither-experts-review-death-expertise-thoughts-biopharma/deathofexpertise/2017-07-19T19:25:08+00:00https://timmermanreport.com/wp-content/uploads/2017/07/deathofexpertise.jpghttps://timmermanreport.com/2017/07/whither-experts-review-death-expertise-thoughts-biopharma/macarthurtweet/2017-07-19T19:25:57+00:00https://timmermanreport.com/wp-content/uploads/2017/07/macarthurtweet.pnghttps://timmermanreport.com/2017/07/vertexs-grand-slam-cf-puma-stretches-price-sarepta-biomarin-bury-hatchet/shorts/2017-07-20T23:58:27+00:00https://timmermanreport.com/wp-content/uploads/2017/07/shorts.pnghttps://timmermanreport.com/2017/07/vertexs-grand-slam-cf-puma-stretches-price-sarepta-biomarin-bury-hatchet/geniuses/2017-07-20T23:59:11+00:00https://timmermanreport.com/wp-content/uploads/2017/07/geniuses.pnghttps://timmermanreport.com/2017/07/vertexs-grand-slam-cf-puma-stretches-price-sarepta-biomarin-bury-hatchet/pumatweets/2017-07-21T00:01:23+00:00https://timmermanreport.com/wp-content/uploads/2017/07/pumatweets.jpghttps://timmermanreport.com/2017/07/agios-neurocrine-striving-mature-hold-onto-souls/schenkein/2017-07-21T23:13:40+00:00https://timmermanreport.com/wp-content/uploads/2017/07/schenkein.jpghttps://timmermanreport.com/2017/08/grail-plucks-low-hanging-fruit-egenesis-creates-perv-free-pigs-roivant-raises-1b/brookings/2017-08-10T22:07:36+00:00https://timmermanreport.com/wp-content/uploads/2017/08/brookings.jpghttps://timmermanreport.com/the-long-run/biotech\_5-650x360/2017-08-11T01:04:06+00:00https://timmermanreport.com/wp-content/uploads/2017/08/Biotech\_5-650x360.jpghttps://timmermanreport.com/the-long-run/long-run-cover/2017-08-11T02:41:56+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LONG-run-cover.jpghttps://timmermanreport.com/the-long-run/long-run-cover-2/2017-08-11T02:50:51+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LONG-run-cover-1.jpghttps://timmermanreport.com/the-long-run/long-run-cover-3/2017-08-11T02:54:22+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LONG-run-cover-2.jpghttps://timmermanreport.com/the-long-run/long-run-cover-4/2017-08-11T02:56:30+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LONG-run-cover-3.jpghttps://timmermanreport.com/the-long-run/long-run-cover-5/2017-08-11T03:00:47+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LONG-run-cover-4.jpghttps://timmermanreport.com/the-long-run/long-run-cover2/2017-08-11T03:06:53+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LONG-run-cover2.jpghttps://timmermanreport.com/the-long-run/longrunbanner/2017-08-11T03:11:46+00:00https://timmermanreport.com/wp-content/uploads/2017/08/LongRunBanner.jpghttps://timmermanreport.com/2017/08/manage-biotech-information-think-widely-deeply/vix/2017-08-12T00:15:29+00:00https://timmermanreport.com/wp-content/uploads/2017/08/vix.pnghttps://timmermanreport.com/2017/08/manage-biotech-information-think-widely-deeply/bruce-booth-web-bio/2017-08-12T00:18:46+00:00https://timmermanreport.com/wp-content/uploads/2017/08/Bruce-Booth-Web-Bio.jpghttps://timmermanreport.com/2017/08/can-follow-charlottesville/stevegraham/2017-08-16T22:13:00+00:00https://timmermanreport.com/wp-content/uploads/2017/08/stevegraham.jpghttps://timmermanreport.com/2017/08/can-follow-charlottesville/sgraham/2017-08-17T00:04:47+00:00https://timmermanreport.com/wp-content/uploads/2017/08/sgraham.jpghttps://timmermanreport.com/2017/08/8680/mrkstatement/2017-08-17T22:28:18+00:00https://timmermanreport.com/wp-content/uploads/2017/08/mrkstatement.pnghttps://timmermanreport.com/2017/08/8680/colestweet/2017-08-17T22:29:17+00:00https://timmermanreport.com/wp-content/uploads/2017/08/colestweet.pnghttps://timmermanreport.com/2017/08/8680/chartweets/2017-08-17T22:30:26+00:00https://timmermanreport.com/wp-content/uploads/2017/08/chartweets.pnghttps://timmermanreport.com/2017/08/scott-gottliebs-first-100-days-fda-rundown/gottcollins/2017-08-18T23:25:19+00:00https://timmermanreport.com/wp-content/uploads/2017/08/gottcollins.pnghttps://timmermanreport.com/2017/08/scott-gottliebs-first-100-days-fda-rundown/fdatwitter/2017-08-18T23:26:03+00:00https://timmermanreport.com/wp-content/uploads/2017/08/fdatwitter.pnghttps://timmermanreport.com/2017/08/scott-gottliebs-first-100-days-fda-rundown/gottslavitt/2017-08-18T23:27:35+00:00https://timmermanreport.com/wp-content/uploads/2017/08/gottslavitt.pnghttps://timmermanreport.com/2017/08/scott-gottliebs-first-100-days-fda-rundown/gottsharfstein/2017-08-18T23:28:23+00:00https://timmermanreport.com/wp-content/uploads/2017/08/gottsharfstein.pnghttps://timmermanreport.com/2017/08/scott-gottliebs-first-100-days-fda-rundown/gottsharpless/2017-08-18T23:29:48+00:00https://timmermanreport.com/wp-content/uploads/2017/08/gottsharpless.pnghttps://timmermanreport.com/2017/08/scott-gottliebs-first-100-days-fda-rundown/gottcompound/2017-08-18T23:30:40+00:00https://timmermanreport.com/wp-content/uploads/2017/08/gottcompound.pnghttps://timmermanreport.com/2017/08/scott-gottliebs-first-100-days-fda-rundown/gottcures/2017-08-18T23:31:35+00:00https://timmermanreport.com/wp-content/uploads/2017/08/gottcures.pnghttps://timmermanreport.com/2017/08/scott-gottliebs-first-100-days-fda-rundown/gottcaliff/2017-08-18T23:32:43+00:00https://timmermanreport.com/wp-content/uploads/2017/08/gottcaliff.pnghttps://timmermanreport.com/2017/08/scott-gottliebs-first-100-days-fda-rundown/gottprice/2017-08-18T23:34:01+00:00https://timmermanreport.com/wp-content/uploads/2017/08/gottprice.pnghttps://timmermanreport.com/2017/08/scott-gottliebs-first-100-days-fda-rundown/gottsharf/2017-08-18T23:35:01+00:00https://timmermanreport.com/wp-content/uploads/2017/08/gottsharf.jpghttps://timmermanreport.com/2017/08/scott-gottliebs-first-100-days-fda-rundown/gotthatch/2017-08-18T23:35:45+00:00https://timmermanreport.com/wp-content/uploads/2017/08/gotthatch.pnghttps://timmermanreport.com/2017/08/scott-gottliebs-first-100-days-fda-rundown/gottcaliffshar/2017-08-18T23:37:15+00:00https://timmermanreport.com/wp-content/uploads/2017/08/gottcaliffshar.pnghttps://timmermanreport.com/2017/08/scott-gottliebs-first-100-days-fda-rundown/gottgrassley/2017-08-18T23:38:26+00:00https://timmermanreport.com/wp-content/uploads/2017/08/gottgrassley.pnghttps://timmermanreport.com/2017/08/adamas-wins-parkinsons-drug-approval-genmab-soars-amgen-defends-pcsk9-price/genmab/2017-08-25T15:40:00+00:00https://timmermanreport.com/wp-content/uploads/2017/08/genmab.pnghttps://timmermanreport.com/2017/08/adamas-wins-parkinsons-drug-approval-genmab-soars-amgen-defends-pcsk9-price/darzalexsales/2017-08-25T15:40:35+00:00https://timmermanreport.com/wp-content/uploads/2017/08/darzalexsales.pnghttps://timmermanreport.com/2017/08/getting-precision-medicine-complicated/cdxtable/2017-08-25T18:16:19+00:00https://timmermanreport.com/wp-content/uploads/2017/08/cdxtable.jpghttps://timmermanreport.com/2017/08/gilead-can-play-win-car-t-next-decade/rosenberg-steven-2/2017-08-31T00:19:01+00:00https://timmermanreport.com/wp-content/uploads/2017/08/rosenberg-steven-2.jpghttps://timmermanreport.com/2017/09/replimune-led-biovex-vets-snags-55m-new-oncolytic-viruses-cancer/rob-coffin/2017-09-07T19:20:57+00:00https://timmermanreport.com/2017/09/replimune-led-biovex-vets-snags-55m-new-oncolytic-viruses-cancer/robcoffin/2017-09-07T19:22:22+00:00https://timmermanreport.com/wp-content/uploads/2017/09/robcoffin.jpghttps://timmermanreport.com/2017/09/allergans-tribal-patent-switcheroo-cellectis-alnylam-see-trial-deaths-execs-defend-dreamers/entreps/2017-09-08T21:08:53+00:00https://timmermanreport.com/wp-content/uploads/2017/09/entreps.pnghttps://timmermanreport.com/2015/05/whats-real-and-whats-not-in-digital-health/jpapanek/2017-09-09T01:18:16+00:00https://timmermanreport.com/wp-content/uploads/2015/05/jpapanek.pnghttps://timmermanreport.com/2017/09/long-run-ep-1-conversation-alnylam-ceo-john-maraganore/long-run-website-banner-290x340-2/2017-09-13T03:29:13+00:00https://timmermanreport.com/wp-content/uploads/2017/08/Long-Run-website-banner-290x340-1.jpghttps://timmermanreport.com/2017/09/alnylam-gets-hump-venter-accused-running-boys-club-biosimilar-avastin-arrives/biosims/2017-09-22T00:07:08+00:00https://timmermanreport.com/wp-content/uploads/2017/09/biosims.pnghttps://timmermanreport.com/2017/09/socializing-hours-biotech-runs-open/hopkins-2/2017-09-23T00:27:35+00:00https://timmermanreport.com/wp-content/uploads/2017/09/hopkins.jpghttps://timmermanreport.com/2017/09/socializing-hours-biotech-runs-open/urban/2017-09-23T00:29:12+00:00https://timmermanreport.com/wp-content/uploads/2017/09/urban.jpghttps://timmermanreport.com/2017/09/socializing-hours-biotech-runs-open/rtb2017/2017-09-23T00:34:09+00:00https://timmermanreport.com/wp-content/uploads/2017/09/rtb2017.jpghttps://timmermanreport.com/2017/05/parting-thoughts-genzyme-ceo-david-meeker/meeker/2017-09-29T22:59:18+00:00https://timmermanreport.com/wp-content/uploads/2017/05/meeker.jpghttps://timmermanreport.com/2017/10/nimbus-rinses-repeats-entices-celgene-immunology-drug-candidates/donnicholson/2017-10-02T23:47:08+00:00https://timmermanreport.com/wp-content/uploads/2017/10/donnicholson.jpghttps://timmermanreport.com/2017/10/ipo-market-finds-rhythm-fda-huddles-ftc-pricing-praluent-gets-stay/obamacidara/2017-10-05T23:47:53+00:00https://timmermanreport.com/wp-content/uploads/2017/10/obamacidara.pnghttps://timmermanreport.com/2017/10/ipo-market-finds-rhythm-fda-huddles-ftc-pricing-praluent-gets-stay/maraganoreprice/2017-10-05T23:50:20+00:00https://timmermanreport.com/wp-content/uploads/2017/10/maraganoreprice.pnghttps://timmermanreport.com/2017/10/george-yancopoulos-threading-price-needle-building-biotech-last/georgey/2017-10-10T16:53:21+00:00https://timmermanreport.com/wp-content/uploads/2017/10/georgey.jpghttps://timmermanreport.com/2017/10/spark-gene-therapy-sails-thru-adcomm-broad-institute-nuzzles-deerfield-pfizers-cancer-deal-africa/oncemeg/2017-10-13T15:38:42+00:00https://timmermanreport.com/wp-content/uploads/2017/10/oncemeg.pnghttps://timmermanreport.com/2017/10/spark-gene-therapy-sails-thru-adcomm-broad-institute-nuzzles-deerfield-pfizers-cancer-deal-africa/frieden/2017-10-13T15:39:40+00:00https://timmermanreport.com/wp-content/uploads/2017/10/frieden.pnghttps://timmermanreport.com/2017/10/spark-gene-therapy-sails-thru-adcomm-broad-institute-nuzzles-deerfield-pfizers-cancer-deal-africa/maris/2017-10-13T15:40:20+00:00https://timmermanreport.com/wp-content/uploads/2017/10/maris.pnghttps://timmermanreport.com/2017/10/exclusive-illumina-ventures-rakes-230m-fund-declares-independence-parent-mostly/naclerio/2017-10-14T00:22:31+00:00https://timmermanreport.com/wp-content/uploads/2017/10/naclerio.pnghttps://timmermanreport.com/2017/10/climbing-everest-for-cancer-research/mt-everest/2017-10-16T19:05:33+00:00https://timmermanreport.com/wp-content/uploads/2017/10/Mt.Everest.jpghttps://timmermanreport.com/2017/10/climbing-everest-for-cancer-research/nepal-quake/2017-10-16T19:31:40+00:00https://timmermanreport.com/wp-content/uploads/2017/10/mount-everest-moved-nepal-earthquake.jpghttps://timmermanreport.com/2017/06/find-biotech-startup-cash-without-traditional-vcs/chubbert/2017-10-18T00:09:58+00:00https://timmermanreport.com/wp-content/uploads/2017/06/CHubbert-e1498678944331.jpghttps://timmermanreport.com/2017/10/gileads-thrilling-car-t-victory-celgenes-agonizing-crohns-defeat-vir-goes-big/boothcelg/2017-10-20T01:07:38+00:00https://timmermanreport.com/wp-content/uploads/2017/10/boothcelg.pnghttps://timmermanreport.com/2017/10/gileads-thrilling-car-t-victory-celgenes-agonizing-crohns-defeat-vir-goes-big/armstrong/2017-10-20T01:08:34+00:00https://timmermanreport.com/wp-content/uploads/2017/10/armstrong.pnghttps://timmermanreport.com/2017/10/biomarin-history-contains-rare-insight-rare-disease-business/rarebreed/2017-10-20T23:11:34+00:00https://timmermanreport.com/wp-content/uploads/2017/10/rarebreed.jpghttps://timmermanreport.com/2017/10/abbvie-shells-205m-upfront-rights-two-alector-alzheimers-targets/arnon/2017-10-24T03:58:09+00:00https://timmermanreport.com/wp-content/uploads/2017/10/arnon.pnghttps://timmermanreport.com/2015/02/thoughts-strategic-use-new-capital/rfpops\_head/2017-10-24T23:10:37+00:00https://timmermanreport.com/wp-content/uploads/2015/01/rFPops\_head.pnghttps://timmermanreport.com/2017/10/activist-fda-boss-zeroes-opioid-crisis-ptc-shot-crispr-2-0-buzz/califfopioid/2017-10-26T23:51:05+00:00https://timmermanreport.com/wp-content/uploads/2017/10/califfopioid.pnghttps://timmermanreport.com/2017/10/activist-fda-boss-zeroes-opioid-crisis-ptc-shot-crispr-2-0-buzz/gottliebpassage/2017-10-26T23:51:52+00:00https://timmermanreport.com/wp-content/uploads/2017/10/gottliebpassage.pnghttps://timmermanreport.com/2017/10/activist-fda-boss-zeroes-opioid-crisis-ptc-shot-crispr-2-0-buzz/megmis/2017-10-26T23:57:31+00:00https://timmermanreport.com/wp-content/uploads/2017/10/megmis.pnghttps://timmermanreport.com/2017/10/activist-fda-boss-zeroes-opioid-crisis-ptc-shot-crispr-2-0-buzz/img\_2371-2/2017-10-27T00:10:50+00:00https://timmermanreport.com/wp-content/uploads/2017/10/IMG\_2371.jpghttps://timmermanreport.com/in-the-news/geekwire-logo/2017-10-27T19:29:09+00:00https://timmermanreport.com/wp-content/uploads/2016/03/GeekWire-logo.pnghttps://timmermanreport.com/2017/10/kymera-raises-30m-targeted-protein-degradation-new-modality-stir-imagination/kymeralogo/2017-10-28T17:40:15+00:00https://timmermanreport.com/wp-content/uploads/2017/10/kymeralogo.jpghttps://timmermanreport.com/2017/11/understanding-polio-baseball-cancer-sometimes-vital/kylesequence/2017-11-01T15:19:11+00:00https://timmermanreport.com/wp-content/uploads/2017/11/kylesequence.jpghttps://timmermanreport.com/2017/11/understanding-polio-baseball-cancer-sometimes-vital/pitchseq/2017-11-01T15:21:08+00:00https://timmermanreport.com/wp-content/uploads/2017/11/pitchseq.pnghttps://timmermanreport.com/2017/11/understanding-polio-baseball-cancer-sometimes-vital/yudarvishgif/2017-11-01T15:23:56+00:00https://timmermanreport.com/wp-content/uploads/2017/11/YuDarvishGif.gifhttps://timmermanreport.com/2017/11/understanding-polio-baseball-cancer-sometimes-vital/missbats/2017-11-01T15:24:58+00:00https://timmermanreport.com/wp-content/uploads/2017/11/missbats.pnghttps://timmermanreport.com/2017/11/understanding-polio-baseball-cancer-sometimes-vital/adaptive-landscape/2017-11-02T20:06:44+00:00https://timmermanreport.com/wp-content/uploads/2017/11/adaptive-landscape.pnghttps://timmermanreport.com/2017/11/understanding-polio-baseball-cancer-sometimes-vital/boxes-1-2-3/2017-11-02T20:07:58+00:00https://timmermanreport.com/wp-content/uploads/2017/11/Boxes-1-2-3.pnghttps://timmermanreport.com/hood-book/wibookpromegatweet/2017-11-03T12:37:40+00:00https://timmermanreport.com/wp-content/uploads/2016/08/WIbookPromegatweet.jpghttps://timmermanreport.com/2017/11/amazon-prowling-drug-supply-chain-celgenes-ho-hum-bounceback-couple-ipos/alnyions/2017-11-03T14:34:13+00:00https://timmermanreport.com/wp-content/uploads/2017/11/alnyions.pnghttps://timmermanreport.com/2017/11/amazon-prowling-drug-supply-chain-celgenes-ho-hum-bounceback-couple-ipos/junonov3/2017-11-03T14:34:41+00:00https://timmermanreport.com/wp-content/uploads/2017/11/junonov3.pnghttps://timmermanreport.com/2017/11/dark-underbelly-startup-fundraising-working-self-doubt-loneliness/underbelly/2017-11-04T19:57:28+00:00https://timmermanreport.com/wp-content/uploads/2017/11/underbelly.pnghttps://timmermanreport.com/2017/11/long-run-podcast-elias-zerhouni-role-immigrants-science/15812\_zerhouni\_100\_2016/2017-11-08T17:08:30+00:00https://timmermanreport.com/wp-content/uploads/2017/11/15812\_Zerhouni\_100\_2016.jpghttps://timmermanreport.com/2017/11/long-run-podcast-elias-zerhouni-role-immigrants-science/biotechshowcasebanner/2017-11-08T17:08:53+00:00https://timmermanreport.com/wp-content/uploads/2017/11/biotechshowcasebanner.jpghttps://timmermanreport.com/2017/11/oxygen-providing-high-autonomy-ma-model-sign-things-come/aplump/2017-11-12T20:21:15+00:00https://timmermanreport.com/wp-content/uploads/2017/11/aplump.jpghttps://timmermanreport.com/2017/11/former-lilly-exec-lead-hhs-flurry-fda-approvals-gates-bets-100m-alzheimers/andymaster/2017-11-17T01:42:43+00:00https://timmermanreport.com/wp-content/uploads/2017/11/andymaster.pnghttps://timmermanreport.com/2017/11/former-lilly-exec-lead-hhs-flurry-fda-approvals-gates-bets-100m-alzheimers/bradjack/2017-11-17T01:43:27+00:00https://timmermanreport.com/wp-content/uploads/2017/11/bradjack.jpghttps://timmermanreport.com/2017/11/went-sitc-got-tr-post-part-1/sitc1/2017-11-18T23:15:10+00:00https://timmermanreport.com/wp-content/uploads/2017/11/sitc1.pnghttps://timmermanreport.com/2017/11/went-sitc-got-tr-post-part-1/sitc2/2017-11-18T23:15:57+00:00https://timmermanreport.com/wp-content/uploads/2017/11/sitc2.jpghttps://timmermanreport.com/2017/11/went-sitc-got-tr-post-part-1/sitc11/2017-11-18T23:16:56+00:00https://timmermanreport.com/wp-content/uploads/2017/11/sitc11.jpghttps://timmermanreport.com/2017/11/went-sitc-got-tr-post-part-1/sitc3/2017-11-18T23:18:02+00:00https://timmermanreport.com/wp-content/uploads/2017/11/sitc3.tifhttps://timmermanreport.com/2017/11/went-sitc-got-tr-post-part-1/sitc5/2017-11-18T23:18:45+00:00https://timmermanreport.com/wp-content/uploads/2017/11/sitc5.jpghttps://timmermanreport.com/2017/11/went-sitc-got-tr-post-part-1/sitc4/2017-11-18T23:19:34+00:00https://timmermanreport.com/wp-content/uploads/2017/11/sitc4.jpghttps://timmermanreport.com/2017/11/went-sitc-got-tr-post-part-1/sitc6/2017-11-18T23:20:36+00:00https://timmermanreport.com/wp-content/uploads/2017/11/sitc6.jpghttps://timmermanreport.com/2017/11/went-sitc-got-tr-post-part-1/sitc7/2017-11-18T23:21:12+00:00https://timmermanreport.com/wp-content/uploads/2017/11/sitc7.jpghttps://timmermanreport.com/2017/11/went-sitc-got-tr-post-part-1/sitc8/2017-11-18T23:21:53+00:00https://timmermanreport.com/wp-content/uploads/2017/11/sitc8.jpghttps://timmermanreport.com/2017/11/went-sitc-got-tr-post-part-1/sitc9/2017-11-18T23:22:21+00:00https://timmermanreport.com/wp-content/uploads/2017/11/sitc9.jpghttps://timmermanreport.com/2017/11/went-sitc-got-tr-post-part-1/sitc10/2017-11-18T23:22:56+00:00https://timmermanreport.com/wp-content/uploads/2017/11/sitc10.jpghttps://timmermanreport.com/2017/11/codiak-aspiring-make-exosome-drugs-cancer-nabs-76m-march-clinic/codiak\_doug\_williams-2/2017-11-29T03:50:01+00:00https://timmermanreport.com/wp-content/uploads/2017/11/codiak\_Doug\_Williams-2.jpghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/jacob-becraft-headshot/2017-11-29T20:05:36+00:00https://timmermanreport.com/wp-content/uploads/2017/11/Jacob-Becraft-headshot.jpghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/annie-yu-headshot/2017-11-29T20:06:09+00:00https://timmermanreport.com/wp-content/uploads/2017/11/Annie-Yu-headshot.jpghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/amicrobiome1/2017-11-29T20:13:27+00:00https://timmermanreport.com/wp-content/uploads/2017/11/amicrobiome1.pnghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/amicrobiome2/2017-11-29T20:15:04+00:00https://timmermanreport.com/wp-content/uploads/2017/11/amicrobiome2.jpghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/amicrobiome3/2017-11-29T20:15:08+00:00https://timmermanreport.com/wp-content/uploads/2017/11/amicrobiome3.jpghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/amicrobiome4/2017-11-29T20:16:38+00:00https://timmermanreport.com/wp-content/uploads/2017/11/amicrobiome4.jpghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/amicrobiome5/2017-11-29T20:17:20+00:00https://timmermanreport.com/wp-content/uploads/2017/11/amicrobiome5.jpghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/amicrobiome6/2017-11-29T20:17:58+00:00https://timmermanreport.com/wp-content/uploads/2017/11/amicrobiome6.pnghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/yu-ja-huang-headshot/2017-11-30T04:43:42+00:00https://timmermanreport.com/wp-content/uploads/2017/11/Yu-Ja-Huang-headshot.jpghttps://timmermanreport.com/2017/12/foundation-medicine-wins-fda-cms-two-fer-azar-calls-high-drug-prices-biogen-buys-ms-challenger/lisabubble/2017-12-01T01:22:19+00:00https://timmermanreport.com/wp-content/uploads/2017/11/lisabubble.pnghttps://timmermanreport.com/the-long-run/presage\_logopms/2017-12-01T18:26:48+00:00https://timmermanreport.com/wp-content/uploads/2017/12/presage\_logoPMS.bmphttps://timmermanreport.com/the-long-run/presage\_medres\_large/2017-12-01T18:27:09+00:00https://timmermanreport.com/wp-content/uploads/2017/12/presage\_medres\_large.pnghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/nest-bio/2017-12-04T16:11:20+00:00https://timmermanreport.com/wp-content/uploads/2017/12/nest.bio\_.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc1/2017-12-05T23:15:01+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc1.pnghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc2/2017-12-05T23:15:57+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc2.pnghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc4/2017-12-05T23:17:59+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc4.pnghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc5/2017-12-05T23:18:53+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc5.pnghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc6/2017-12-05T23:19:35+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc6.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc7/2017-12-05T23:20:14+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc7.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc8/2017-12-05T23:20:56+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc8.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc9/2017-12-05T23:21:33+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc9.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc10/2017-12-05T23:22:14+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc10.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc11/2017-12-05T23:23:04+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc11.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc12/2017-12-05T23:23:06+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc12.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc13/2017-12-05T23:24:13+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc13.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc14/2017-12-05T23:24:16+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc14.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc15/2017-12-05T23:25:56+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc15.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc16/2017-12-05T23:25:59+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc16.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc17/2017-12-05T23:27:06+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc17.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc18/2017-12-05T23:27:42+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc18.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc19/2017-12-05T23:29:53+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc19.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc20/2017-12-05T23:30:34+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc20.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc21/2017-12-05T23:31:19+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc21.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc22/2017-12-05T23:32:17+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc22.jpghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc23/2017-12-05T23:32:20+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc23.tifhttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc24/2017-12-05T23:33:09+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc24.pnghttps://timmermanreport.com/2017/12/went-sitc-got-tr-post-part-2/blacksitc25/2017-12-05T23:34:02+00:00https://timmermanreport.com/wp-content/uploads/2017/12/blacksitc25.jpghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/mitfig1/2017-12-06T00:12:26+00:00https://timmermanreport.com/wp-content/uploads/2017/12/mitfig1.pnghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/mitfig5/2017-12-06T00:13:50+00:00https://timmermanreport.com/wp-content/uploads/2017/12/mitfig5.pnghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/mitfig2/2017-12-06T00:19:01+00:00https://timmermanreport.com/wp-content/uploads/2017/12/mitfig2.pnghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/mitfig4/2017-12-06T00:20:18+00:00https://timmermanreport.com/wp-content/uploads/2017/12/mitfig4.pnghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/figure-3-1/2017-12-06T16:48:54+00:00https://timmermanreport.com/wp-content/uploads/2017/12/Figure-3-1.pnghttps://timmermanreport.com/2017/12/sage-crushes-depression-trial-sparks-hemophilia-tour-de-force-cvs-aetna-megadeal/moresage/2017-12-08T01:45:45+00:00https://timmermanreport.com/wp-content/uploads/2017/12/moresage.pnghttps://timmermanreport.com/2017/12/biotechs-test-root-tax-windfall-support-next-generation-scientists/taxplan/2017-12-09T23:19:58+00:00https://timmermanreport.com/wp-content/uploads/2017/12/taxplan.pnghttps://timmermanreport.com/2017/12/microbiome-new-technology-commercial-challenges-opportunities/ashvin-bashyam-headshot/2017-12-09T23:21:26+00:00https://timmermanreport.com/wp-content/uploads/2017/11/Ashvin-Bashyam-headshot.jpghttps://timmermanreport.com/2017/04/photos-tr-anniversary-party-boston-marathon/dsc\_0083/2017-12-09T23:22:21+00:00https://timmermanreport.com/wp-content/uploads/2017/04/DSC\_0083.jpghttps://timmermanreport.com/2017/12/accelerator-backed-corporate-vcs-spreads-wings-not-boston-sf/funding\_clusters\_mar2017/2017-12-13T00:14:24+00:00https://timmermanreport.com/wp-content/uploads/2017/12/Funding\_Clusters\_Mar2017.jpghttps://timmermanreport.com/2016/06/bigger-better-biotech-venture-capital/thong-le/2017-12-13T00:15:31+00:00https://timmermanreport.com/wp-content/uploads/2014/12/Thong-Le.jpghttps://timmermanreport.com/2017/12/accelerator-backed-corporate-vcs-spreads-wings-not-boston-sf/mohler/2017-12-13T00:17:13+00:00https://timmermanreport.com/wp-content/uploads/2017/12/mohler.pnghttps://timmermanreport.com/2017/12/a16z-rakes-new-450m-fund-bet-bringing-engineering-biology/pande/2017-12-14T00:28:33+00:00https://timmermanreport.com/wp-content/uploads/2017/12/pande-e1513211292758.jpghttps://timmermanreport.com/2017/12/a16z-rakes-new-450m-fund-bet-bringing-engineering-biology/jorge-conde-e1506726522541/2017-12-14T00:31:47+00:00https://timmermanreport.com/wp-content/uploads/2017/12/jorge-conde-e1506726522541.pnghttps://timmermanreport.com/2017/11/will-great-sex-predator-purge-alter-gender-dynamics-work/nancysimonian/2017-12-17T19:14:44+00:00https://timmermanreport.com/wp-content/uploads/2017/11/nancysimonian.jpghttps://timmermanreport.com/hood-book/kirkusbest2017/2017-12-20T03:27:00+00:00https://timmermanreport.com/wp-content/uploads/2017/12/kirkusbest2017.jpghttps://timmermanreport.com/hood-book/best2017/2017-12-20T03:33:06+00:00https://timmermanreport.com/wp-content/uploads/2017/12/best2017.jpghttps://timmermanreport.com/2015/08/not-just-research-not-just-diagnostics-adaptive-veers-into-t-cell-drug-discovery/harlan-robins\_2/2018-01-04T00:58:46+00:00https://timmermanreport.com/wp-content/uploads/2015/01/harlan-robins\_2.jpghttps://timmermanreport.com/2018/01/microsoft-makes-nine-figure-bet-adaptives-tcr-antigen-map-biontech-hauls-270m-10-drug-cancer-pipeline/sean-marett\_web/2018-01-04T01:00:33+00:00https://timmermanreport.com/wp-content/uploads/2018/01/Sean-Marett\_web.jpghttps://timmermanreport.com/2018/01/spark-sets-850k-bar-microsofts-bet-ai-immune-mapping-ton-vc-deals/megwells/2018-01-05T00:40:28+00:00https://timmermanreport.com/wp-content/uploads/2018/01/megwells.pnghttps://timmermanreport.com/2018/01/celgene-buys-impact-1-1b-upfront-regeneron-rounds-60m-friends-uk-biobank-pfizer-drops-neuro-pre-jpm18-roundup/grainger/2018-01-08T05:09:57+00:00https://timmermanreport.com/wp-content/uploads/2018/01/grainger.pnghttps://timmermanreport.com/2018/01/celgene-buys-impact-1-1b-upfront-regeneron-rounds-60m-friends-uk-biobank-pfizer-drops-neuro-pre-jpm18-roundup/nobhill1/2018-01-08T05:20:01+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhill1.jpghttps://timmermanreport.com/2018/01/getting-seat-table-long-run-podcast-abbie-celniker/acelniker/2018-01-16T18:17:30+00:00https://timmermanreport.com/wp-content/uploads/2018/01/acelniker.jpghttps://timmermanreport.com/2018/01/reverse-engineering-o-bispecifics-autoimmunity-pandion-snags-58m/acoyle/2018-01-18T00:31:27+00:00https://timmermanreport.com/wp-content/uploads/2018/01/acoyle.pnghttps://timmermanreport.com/2018/01/reverse-engineering-o-bispecifics-autoimmunity-pandion-snags-58m/jviney/2018-01-18T00:32:05+00:00https://timmermanreport.com/wp-content/uploads/2018/01/jviney.pnghttps://timmermanreport.com/2018/01/celgenes-rumored-juno-bid-hospitals-shoot-generic-drugmakers-keytruda-hits-phase-iii/nikhil/2018-01-18T23:48:04+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nikhil.pnghttps://timmermanreport.com/2018/01/celgenes-rumored-juno-bid-hospitals-shoot-generic-drugmakers-keytruda-hits-phase-iii/crls/2018-01-18T23:49:35+00:00https://timmermanreport.com/wp-content/uploads/2018/01/crls.pnghttps://timmermanreport.com/2018/01/celgenes-rumored-juno-bid-hospitals-shoot-generic-drugmakers-keytruda-hits-phase-iii/wilson/2018-01-18T23:51:33+00:00https://timmermanreport.com/wp-content/uploads/2018/01/wilson.pnghttps://timmermanreport.com/2018/01/training-update-everest-climb-fight-cancer-fred-hutch-january/sam/2018-01-20T22:49:01+00:00https://timmermanreport.com/wp-content/uploads/2018/01/sam.pnghttps://timmermanreport.com/2018/01/training-update-everest-climb-fight-cancer-fred-hutch-january/sijan20/2018-01-20T22:52:20+00:00https://timmermanreport.com/wp-content/uploads/2018/01/sijan20.jpghttps://timmermanreport.com/2018/01/levering-junes-o-team-penn-tmunity-fetches-100m-gilead-parker-ping/azam/2018-01-23T01:01:56+00:00https://timmermanreport.com/wp-content/uploads/2018/01/azam.jpghttps://timmermanreport.com/2018/01/celgene-pulls-trigger-juno-azar-confirmed-half-hearted-gene-editing/herper/2018-01-26T00:52:44+00:00https://timmermanreport.com/wp-content/uploads/2018/01/herper.pnghttps://timmermanreport.com/2018/01/celgene-pulls-trigger-juno-azar-confirmed-half-hearted-gene-editing/moregeneediting/2018-01-26T00:54:18+00:00https://timmermanreport.com/wp-content/uploads/2018/01/moregeneediting.pnghttps://timmermanreport.com/2018/01/celgene-pulls-trigger-juno-azar-confirmed-half-hearted-gene-editing/adamsolid/2018-01-26T01:06:49+00:00https://timmermanreport.com/wp-content/uploads/2018/01/adamsolid.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/everestsuit/2018-01-29T16:27:52+00:00https://timmermanreport.com/wp-content/uploads/2018/01/everestsuit.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhillday4/2018-01-29T16:27:55+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhillday4.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhillda3/2018-01-29T16:27:58+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhillda3.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhillday2/2018-01-29T16:28:02+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhillday2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhillday1/2018-01-29T16:28:05+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhillday1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhillbrad/2018-01-29T16:28:09+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhillbrad.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhilltruex/2018-01-29T16:28:12+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhilltruex.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhilldybbs/2018-01-29T16:28:15+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhilldybbs.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/samelite/2018-01-29T16:28:19+00:00https://timmermanreport.com/wp-content/uploads/2018/01/samelite.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/sijan202018/2018-01-29T16:28:29+00:00https://timmermanreport.com/wp-content/uploads/2018/01/sijan202018.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/kiddo/2018-01-29T16:28:35+00:00https://timmermanreport.com/wp-content/uploads/2018/01/kiddo.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/lungemovie/2018-01-29T16:28:45+00:00https://timmermanreport.com/everest-fundraiser-for-cancer-research/ltlunge/2018-01-29T16:28:49+00:00https://timmermanreport.com/wp-content/uploads/2018/01/ltlunge.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhill1-2/2018-01-29T16:28:56+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhill1-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/mtsitalus/2018-01-29T16:34:00+00:00https://timmermanreport.com/wp-content/uploads/2018/01/mtsitalus.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nancyonhowe/2018-01-29T16:36:04+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nancyonhowe.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/coldwet/2018-01-29T16:36:05+00:00https://timmermanreport.com/wp-content/uploads/2018/01/coldwet.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/whatsyourmountain/2018-01-29T16:36:08+00:00https://timmermanreport.com/wp-content/uploads/2018/01/whatsyourmountain.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nancyonhowe-2/2018-01-29T16:51:00+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nancyonhowe-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/coldwet-2/2018-01-29T16:51:03+00:00https://timmermanreport.com/wp-content/uploads/2018/01/coldwet-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/whatsyourmountain-2/2018-01-29T16:51:06+00:00https://timmermanreport.com/wp-content/uploads/2018/01/whatsyourmountain-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/everestsuit-2/2018-01-29T16:51:09+00:00https://timmermanreport.com/wp-content/uploads/2018/01/everestsuit-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhillday4-2/2018-01-29T16:51:13+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhillday4-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhillda3-2/2018-01-29T16:51:16+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhillda3-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhillday2-2/2018-01-29T16:51:20+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhillday2-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhillday1-2/2018-01-29T16:51:23+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhillday1-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhillbrad-2/2018-01-29T16:51:26+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhillbrad-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhilltruex-2/2018-01-29T16:51:30+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhilltruex-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhilldybbs-2/2018-01-29T16:51:33+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhilldybbs-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/samelite-2/2018-01-29T16:51:37+00:00https://timmermanreport.com/wp-content/uploads/2018/01/samelite-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/sijan202018-2/2018-01-29T16:51:45+00:00https://timmermanreport.com/wp-content/uploads/2018/01/sijan202018-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/kiddo-2/2018-01-29T16:51:51+00:00https://timmermanreport.com/wp-content/uploads/2018/01/kiddo-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/lungemovie-2/2018-01-29T16:52:00+00:00https://timmermanreport.com/everest-fundraiser-for-cancer-research/ltlunge-2/2018-01-29T16:52:03+00:00https://timmermanreport.com/wp-content/uploads/2018/01/ltlunge-1.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhill1-3/2018-01-29T16:52:11+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhill1-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/mtsitalus-2/2018-01-29T16:57:26+00:00https://timmermanreport.com/wp-content/uploads/2018/01/mtsitalus-1.jpghttps://timmermanreport.com/2018/01/state-laws-zero-rising-drug-costs/leorat1/2018-01-29T21:05:04+00:00https://timmermanreport.com/wp-content/uploads/2018/01/leorat1.jpghttps://timmermanreport.com/2018/01/state-laws-zero-rising-drug-costs/leorat2/2018-01-29T21:05:35+00:00https://timmermanreport.com/wp-content/uploads/2018/01/leorat2-e1517260140606.jpghttps://timmermanreport.com/2018/01/state-laws-zero-rising-drug-costs/leorat3/2018-01-29T21:06:13+00:00https://timmermanreport.com/wp-content/uploads/2018/01/leorat3.jpghttps://timmermanreport.com/2018/01/state-laws-zero-rising-drug-costs/leorat4/2018-01-29T21:06:51+00:00https://timmermanreport.com/wp-content/uploads/2018/01/leorat4.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/mtsitalus-3/2018-01-29T21:20:08+00:00https://timmermanreport.com/wp-content/uploads/2018/01/mtsitalus-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nancyonhowe-3/2018-01-29T21:20:11+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nancyonhowe-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/coldwet-3/2018-01-29T21:20:14+00:00https://timmermanreport.com/wp-content/uploads/2018/01/coldwet-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/whatsyourmountain-3/2018-01-29T21:20:17+00:00https://timmermanreport.com/wp-content/uploads/2018/01/whatsyourmountain-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/everestsuit-3/2018-01-29T21:20:20+00:00https://timmermanreport.com/wp-content/uploads/2018/01/everestsuit-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhillday4-3/2018-01-29T21:20:24+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhillday4-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhillda3-3/2018-01-29T21:20:27+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhillda3-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhillday2-3/2018-01-29T21:20:30+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhillday2-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhillday1-3/2018-01-29T21:20:34+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhillday1-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhillbrad-3/2018-01-29T21:20:38+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhillbrad-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhilltruex-3/2018-01-29T21:20:44+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhilltruex-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhilldybbs-3/2018-01-29T21:20:49+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhilldybbs-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/samelite-3/2018-01-29T21:20:54+00:00https://timmermanreport.com/wp-content/uploads/2018/01/samelite-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/sijan202018-3/2018-01-29T21:21:03+00:00https://timmermanreport.com/wp-content/uploads/2018/01/sijan202018-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/kiddo-3/2018-01-29T21:21:08+00:00https://timmermanreport.com/wp-content/uploads/2018/01/kiddo-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/ltlunge-3/2018-01-29T21:21:18+00:00https://timmermanreport.com/wp-content/uploads/2018/01/ltlunge-2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/nobhill1-4/2018-01-29T21:21:25+00:00https://timmermanreport.com/wp-content/uploads/2018/01/nobhill1-3.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/mailbox/2018-01-30T20:00:38+00:00https://timmermanreport.com/wp-content/uploads/2018/01/mailbox.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/mailboxpeak/2018-01-31T16:54:55+00:00https://timmermanreport.com/wp-content/uploads/2018/01/mailboxpeak.jpghttps://timmermanreport.com/2018/02/amazon-sizes-healthcare-beast-vertex-raises-bar-cf-moderna-hauls-another-500m/bradearnings/2018-02-01T23:45:47+00:00https://timmermanreport.com/wp-content/uploads/2018/02/bradearnings.pnghttps://timmermanreport.com/2018/02/amazon-sizes-healthcare-beast-vertex-raises-bar-cf-moderna-hauls-another-500m/andygtx/2018-02-01T23:46:40+00:00https://timmermanreport.com/wp-content/uploads/2018/02/andygtx.pnghttps://timmermanreport.com/2018/02/cavemans-guide-to-productivity-entrepreneur-family-everest/badass/2018-02-02T22:26:32+00:00https://timmermanreport.com/wp-content/uploads/2018/02/badass.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/elitethanks/2018-02-05T17:42:30+00:00https://timmermanreport.com/wp-content/uploads/2018/02/elitethanks-e1517852579332.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/takedalogo/2018-02-06T03:32:48+00:00https://timmermanreport.com/wp-content/uploads/2018/02/TakedaLogo.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/arelogo/2018-02-06T03:32:48+00:00https://timmermanreport.com/wp-content/uploads/2018/02/ARElogo-e1550252587687.pnghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/10xgenomics/2018-02-06T03:38:31+00:00https://timmermanreport.com/wp-content/uploads/2018/02/10xgenomics.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/10x-genomics/2018-02-06T03:42:04+00:00https://timmermanreport.com/wp-content/uploads/2018/02/10x-genomics.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/komo-thumb/2018-02-06T03:47:12+00:00https://timmermanreport.com/wp-content/uploads/2018/02/komo-thumb.jpghttps://timmermanreport.com/2018/02/bms-makes-case-tmb-express-scripts-sees-drug-price-slowdown-theravance-pockets-100m/karlin/2018-02-08T22:00:04+00:00https://timmermanreport.com/wp-content/uploads/2018/02/karlin.pnghttps://timmermanreport.com/2018/02/bms-makes-case-tmb-express-scripts-sees-drug-price-slowdown-theravance-pockets-100m/gildhcv/2018-02-08T22:01:19+00:00https://timmermanreport.com/wp-content/uploads/2018/02/gildhcv.pnghttps://timmermanreport.com/2018/02/bms-makes-case-tmb-express-scripts-sees-drug-price-slowdown-theravance-pockets-100m/suennen/2018-02-08T22:02:17+00:00https://timmermanreport.com/wp-content/uploads/2018/02/suennen.pnghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/ascendingwreiter/2018-02-13T21:51:46+00:00https://timmermanreport.com/wp-content/uploads/2018/02/AscendingwReiter.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/cleanshirt2/2018-02-13T21:51:49+00:00https://timmermanreport.com/wp-content/uploads/2018/02/CleanShirt2.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/listeningtojangbu/2018-02-13T21:51:54+00:00https://timmermanreport.com/wp-content/uploads/2018/02/ListeningtoJangbu.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/panpoint/2018-02-13T21:51:59+00:00https://timmermanreport.com/wp-content/uploads/2018/02/PanPoint.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/practiceatpanpoint/2018-02-13T21:52:03+00:00https://timmermanreport.com/wp-content/uploads/2018/02/PracticeatPanPoint.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/rainierinfeb/2018-02-13T21:52:06+00:00https://timmermanreport.com/wp-content/uploads/2018/02/RainierinFeb.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/sleddograinerfeb18/2018-02-13T21:52:11+00:00https://timmermanreport.com/wp-content/uploads/2018/02/SledDogRainerFeb18.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/snacktime/2018-02-13T21:52:15+00:00https://timmermanreport.com/wp-content/uploads/2018/02/SnackTime.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/manglessladder/2018-02-13T21:56:45+00:00https://timmermanreport.com/wp-content/uploads/2018/02/Manglessladder.jpghttps://timmermanreport.com/2018/02/underdog-making-cancer-rd-engine-last-david-schenkein-long-run/bes18\_banners\_msg2\_600x200/2018-02-13T22:31:46+00:00https://timmermanreport.com/wp-content/uploads/2018/02/BES18\_Banners\_msg2\_600x200.jpghttps://timmermanreport.com/the-long-run/ebd-2/2018-02-13T23:09:36+00:00https://timmermanreport.com/wp-content/uploads/2018/02/EBD-e1518563449657.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/stephenwadsworth/2018-02-14T23:20:42+00:00https://timmermanreport.com/wp-content/uploads/2018/02/stephenwadsworth.jpghttps://timmermanreport.com/2018/02/genentech-celgene-orbimed-5am-dont-miss-seattle-cancer-summit-mar-5/rob-hershberg\_202/2018-02-15T00:52:55+00:00https://timmermanreport.com/wp-content/uploads/2018/02/Rob-Hershberg\_202.jpghttps://timmermanreport.com/2018/02/genentech-celgene-orbimed-5am-dont-miss-seattle-cancer-summit-mar-5/shendure-2/2018-02-15T00:56:19+00:00https://timmermanreport.com/wp-content/uploads/2018/02/shendure.jpghttps://timmermanreport.com/2018/02/star-lineup-boston-cancer-summit-march-7-novartis-jj-az-third-rock-atlas/jbradner/2018-02-15T20:47:16+00:00https://timmermanreport.com/wp-content/uploads/2018/02/jbradner.pnghttps://timmermanreport.com/2018/02/star-lineup-boston-cancer-summit-march-7-novartis-jj-az-third-rock-atlas/kush\_131444-cropped-2-175x197/2018-02-15T20:55:03+00:00https://timmermanreport.com/wp-content/uploads/2018/02/Kush\_131444-cropped-2-175x197.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/novateur/2018-02-18T02:51:20+00:00https://timmermanreport.com/wp-content/uploads/2018/02/novateur.pnghttps://timmermanreport.com/2018/02/henri-termeer-tribute-uplifting-idea-tumultuous-time/termeer/2018-02-23T22:23:16+00:00https://timmermanreport.com/wp-content/uploads/2018/02/termeer.jpghttps://timmermanreport.com/in-the-news/fred\_hutch\_logo/2018-03-01T18:31:58+00:00https://timmermanreport.com/wp-content/uploads/2018/03/fred\_hutch\_logo.pnghttps://timmermanreport.com/2018/03/whats-better-curing-cancer-preventing/slyman/2018-03-05T02:47:18+00:00https://timmermanreport.com/wp-content/uploads/2018/03/slyman.jpghttps://timmermanreport.com/2018/03/whats-better-curing-cancer-preventing/stewart\_hpv-03-650/2018-03-05T02:50:23+00:00https://timmermanreport.com/wp-content/uploads/2018/03/Stewart\_HPV-03-650.pnghttps://timmermanreport.com/2018/03/photo-gallery-boston-cancer-summit/presidentt/2018-03-10T19:32:42+00:00https://timmermanreport.com/wp-content/uploads/2018/03/PresidentT.jpghttps://timmermanreport.com/2018/03/photo-gallery-boston-cancer-summit/dsc00801/2018-03-10T19:33:17+00:00https://timmermanreport.com/wp-content/uploads/2018/03/DSC00801.jpghttps://timmermanreport.com/2018/03/shkreli-goes-to-jail-holmes-gets-fined-gilead-cso-exits-with-barely-a-peep/aveytweet/2018-03-15T23:48:55+00:00https://timmermanreport.com/wp-content/uploads/2018/03/aveytweet.pnghttps://timmermanreport.com/2018/03/shkreli-goes-to-jail-holmes-gets-fined-gilead-cso-exits-with-barely-a-peep/tobaccotweet/2018-03-15T23:49:40+00:00https://timmermanreport.com/wp-content/uploads/2018/03/tobaccotweet.jpghttps://timmermanreport.com/the-long-run/hms\_execed-horiz\_cmyk\_a/2018-03-19T17:44:11+00:00https://timmermanreport.com/wp-content/uploads/2018/03/HMS\_ExecEd-Horiz\_CMYK\_A-e1521481543954.jpghttps://timmermanreport.com/2018/03/teaching-and-mentoring-the-next-generation-vicki-sato-on-the-long-run-podcast/vickisato/2018-03-19T18:19:38+00:00https://timmermanreport.com/wp-content/uploads/2015/01/vickisato.jpghttps://timmermanreport.com/2018/03/tcr2-therapeutics-grabs-125m-to-take-tcr-therapies-sans-hla-screens-to-the-clinic/garrymenzel/2018-03-20T23:08:07+00:00https://timmermanreport.com/wp-content/uploads/2018/03/garrymenzel.jpghttps://timmermanreport.com/2016/04/seattleites-join-chad-harlan-robins-interview-tr-party-apr-25/chad\_robins\_ceo\_2015a/2018-03-23T18:01:05+00:00https://timmermanreport.com/wp-content/uploads/2016/04/Chad\_Robins\_CEO\_2015a-e1459985386206.jpghttps://timmermanreport.com/2018/04/what-can-you-do-with-genomics-and-ai-alice-zhang-on-the-long-run/alicezhang/2018-03-23T18:14:14+00:00https://timmermanreport.com/wp-content/uploads/2018/03/alicezhang.jpghttps://timmermanreport.com/2018/05/charting-his-own-entrepreneurial-course-ethan-perlstein-on-the-long-run-podcast/ethan-perlstein-1000x500px-v3/2018-03-23T18:23:40+00:00https://timmermanreport.com/wp-content/uploads/2018/03/Ethan-Perlstein-1000x500px-v3.jpghttps://timmermanreport.com/2017/12/five-things-think-know-happiness/robperez1/2018-03-23T18:39:09+00:00https://timmermanreport.com/wp-content/uploads/2017/12/robperez1.pnghttps://timmermanreport.com/2018/04/challenges-in-creating-and-distributing-mobile-health-tools-qa-with-dr-heather-evans-of-mpower/heather-evans/2018-03-25T18:42:15+00:00https://timmermanreport.com/wp-content/uploads/2018/04/heather-evans.jpghttps://timmermanreport.com/2018/04/harnessing-what-was-there-all-along-book-review-of-a-cure-within/curewithindiagram/2018-03-25T18:47:23+00:00https://timmermanreport.com/wp-content/uploads/2018/03/curewithindiagram.pnghttps://timmermanreport.com/in-the-news/geekwirelogo/2018-03-26T13:50:36+00:00https://timmermanreport.com/wp-content/uploads/2018/03/geekwirelogo.pnghttps://timmermanreport.com/2016/01/should-basic-lab-experiments-be-blinded-to-chip-away-at-the-reproducibility-problem/kyleserikawa/2018-04-15T23:13:59+00:00https://timmermanreport.com/wp-content/uploads/2015/01/kyleserikawa.jpghttps://timmermanreport.com/everest-fundraiser-for-cancer-research/exact-sciences-corp-logo-no-background/2018-04-18T12:37:16+00:00https://timmermanreport.com/wp-content/uploads/2018/04/Exact-Sciences-Corp.-Logo-No-Background.jpghttps://timmermanreport.com/2018/05/luna-dna-brings-blockchain-and-genomics-together/timhay-pic/2018-05-04T08:17:03+00:00https://timmermanreport.com/wp-content/uploads/2018/03/timhay-pic.jpghttps://timmermanreport.com/2018/05/luna-dna-brings-blockchain-and-genomics-together/dawn-barry-president-and-co-founder-luna-dna/2018-05-04T08:22:38+00:00https://timmermanreport.com/wp-content/uploads/2018/05/Dawn-Barry-President-and-Co-founder-Luna-DNA-e1525421604375.pnghttps://timmermanreport.com/2018/05/start-of-a-drug-a-fortuitous-collaboration-part-1-of-3/cells-exploding/2018-05-21T02:09:56+00:00https://timmermanreport.com/wp-content/uploads/2018/05/cells-exploding.jpghttps://timmermanreport.com/2018/05/start-of-a-drug-blueprint-for-building-a-bridge-across-valley-of-death-part-2-of-3/confocal-image/2018-05-28T22:09:03+00:00https://timmermanreport.com/wp-content/uploads/2018/05/confocal-image.jpghttps://timmermanreport.com/2018/05/start-of-a-drug-blueprint-for-building-a-bridge-across-valley-of-death-part-2-of-3/compound-90/2018-05-28T22:11:58+00:00https://timmermanreport.com/wp-content/uploads/2018/05/compound-90.jpghttps://timmermanreport.com/2015/05/baseball-regression-to-the-mean-and-avoiding-potential-clinical-trial-biases/kserikawa/2018-05-31T06:10:20+00:00https://timmermanreport.com/wp-content/uploads/2015/05/kserikawa.pnghttps://timmermanreport.com/2018/06/blazing-a-trail-with-high-tech-treatments-of-the-future/corey-mccann-color-headshot/2018-06-04T21:55:28+00:00https://timmermanreport.com/wp-content/uploads/2018/06/Corey-McCann-Color-Headshot.pnghttps://timmermanreport.com/2018/06/bio18-reflections-axovant-and-ophthotech-reboot-with-gene-therapy-more/tcells/2018-06-07T23:02:55+00:00https://timmermanreport.com/wp-content/uploads/2018/06/tcells.pnghttps://timmermanreport.com/about-luke-timmerman/img\_20180522\_063530119/2018-06-11T18:42:35+00:00https://timmermanreport.com/wp-content/uploads/2018/06/IMG\_20180522\_063530119.jpghttps://timmermanreport.com/2018/06/eha18-preview-blood-drugs-to-watch-in-stockholm/celg18stock/2018-06-12T20:11:33+00:00https://timmermanreport.com/wp-content/uploads/2018/06/celg18stock.pnghttps://timmermanreport.com/2018/06/bluebird-gene-therapy-holding-up-crispr-gyrations-and-a-clever-antibiotic-business-idea/blue1/2018-06-15T03:22:02+00:00https://timmermanreport.com/wp-content/uploads/2018/06/blue1.pnghttps://timmermanreport.com/2018/06/bluebird-gene-therapy-holding-up-crispr-gyrations-and-a-clever-antibiotic-business-idea/blue2/2018-06-15T03:22:50+00:00https://timmermanreport.com/wp-content/uploads/2018/06/blue2.pnghttps://timmermanreport.com/2018/06/bluebird-gene-therapy-holding-up-crispr-gyrations-and-a-clever-antibiotic-business-idea/sage164/2018-06-15T03:24:14+00:00https://timmermanreport.com/wp-content/uploads/2018/06/sage164.pnghttps://timmermanreport.com/2018/06/bluebird-gene-therapy-holding-up-crispr-gyrations-and-a-clever-antibiotic-business-idea/lazarus/2018-06-15T03:24:48+00:00https://timmermanreport.com/wp-content/uploads/2018/06/lazarus.pnghttps://timmermanreport.com/2018/06/so-you-want-to-get-into-biotechpart-1-many-stories-many-paths/laura-strong/2018-06-15T16:20:28+00:00https://timmermanreport.com/wp-content/uploads/2018/06/laura-strong.jpghttps://timmermanreport.com/2018/06/so-you-want-to-get-into-biotechpart-2-banana-peel-what-banana-peel/chris\_larson-8449/2018-06-15T16:57:35+00:00https://timmermanreport.com/wp-content/uploads/2018/06/chris\_larson-8449.jpghttps://timmermanreport.com/2018/06/so-you-want-to-get-into-biotechpart-2-banana-peel-what-banana-peel/jeffreid/2018-06-15T18:36:04+00:00https://timmermanreport.com/wp-content/uploads/2018/06/jeffreid.pnghttps://timmermanreport.com/2018/06/so-you-want-to-get-into-biotechpart-2-banana-peel-what-banana-peel/irenai/2018-06-15T21:13:21+00:00https://timmermanreport.com/wp-content/uploads/2018/06/irenai.jpghttps://timmermanreport.com/2018/06/so-you-want-to-get-into-biotechpart-2-banana-peel-what-banana-peel/c-thut-headshot/2018-06-16T18:21:33+00:00https://timmermanreport.com/wp-content/uploads/2018/06/C-Thut-headshot.jpghttps://timmermanreport.com/in-the-news/komonews/2018-06-19T18:41:33+00:00https://timmermanreport.com/wp-content/uploads/2018/06/KOMONEWS.pnghttps://timmermanreport.com/2018/06/sareptas-stunner-summer-ipo-wave-and-a-white-house-plan-to-clip-wings-at-fda/maiztweet/2018-06-21T23:03:08+00:00https://timmermanreport.com/wp-content/uploads/2018/06/maiztweet.pnghttps://timmermanreport.com/2018/06/sareptas-stunner-summer-ipo-wave-and-a-white-house-plan-to-clip-wings-at-fda/skortweet/2018-06-21T23:04:24+00:00https://timmermanreport.com/wp-content/uploads/2018/06/skortweet.pnghttps://timmermanreport.com/2018/06/amazons-online-pharmacy-chess-move-and-the-pre-holiday-ipo-wave-continues/bijanamzn/2018-06-28T22:52:20+00:00https://timmermanreport.com/wp-content/uploads/2018/06/bijanamzn.pnghttps://timmermanreport.com/in-the-news/fredhutch/2018-07-02T13:23:48+00:00https://timmermanreport.com/wp-content/uploads/2018/07/fredhutch.pnghttps://timmermanreport.com/team/pedrorosado/2018-07-05T14:43:29+00:00https://timmermanreport.com/wp-content/uploads/2018/07/pedrorosado.jpghttps://timmermanreport.com/2018/07/epipen-rival-gets-a-lift-summer-price-increases-bayer-doubles-down-on-broad/brucebigelow/2018-07-05T20:50:02+00:00https://timmermanreport.com/wp-content/uploads/2018/07/brucebigelow.pnghttps://timmermanreport.com/team/steve-white/stevewhiteheadshot/2018-07-06T17:30:22+00:00https://timmermanreport.com/wp-content/uploads/2018/07/stevewhiteheadshot.pnghttps://timmermanreport.com/2018/07/scientist-executive-teacher-vicki-sato-on-the-long-run-podcast/hms\_execed-horiz\_cmyk\_a-2/2018-07-10T16:42:16+00:00https://timmermanreport.com/wp-content/uploads/2018/07/HMS\_ExecEd-Horiz\_CMYK\_A.jpghttps://timmermanreport.com/2018/07/novartis-bails-on-antibiotics-acceleron-goes-2-for-2-grail-ceo-assembles-her-team/vrtxletter/2018-07-12T22:33:29+00:00https://timmermanreport.com/wp-content/uploads/2018/07/vrtxletter.pnghttps://timmermanreport.com/2018/07/hotspot-therapeutics-raises-45m-to-follow-in-nimbus-footsteps-creating-allosteric-binders/jonathan-montagu/2018-07-16T21:59:39+00:00https://timmermanreport.com/wp-content/uploads/2018/07/jonathan-montagu.jpghttps://timmermanreport.com/2018/07/hotspot-therapeutics-raises-45m-to-follow-in-nimbus-footsteps-creating-allosteric-binders/geraldine-harriman/2018-07-16T22:00:22+00:00https://timmermanreport.com/wp-content/uploads/2018/07/geraldine-harriman.jpghttps://timmermanreport.com/2018/07/nine-observations-on-leadership-and-teamwork-from-mt-everest/attachment/15/2018-07-17T22:35:37+00:00https://timmermanreport.com/wp-content/uploads/2018/07/15.jpghttps://timmermanreport.com/2018/07/nine-observations-on-leadership-and-teamwork-from-mt-everest/attachment/27/2018-07-17T22:37:39+00:00https://timmermanreport.com/wp-content/uploads/2018/07/27.jpghttps://timmermanreport.com/2018/07/novartis-merck-back-off-on-prices-rubius-leads-ipo-charge-crispr-stocks-rattled/azar/2018-07-19T23:02:08+00:00https://timmermanreport.com/wp-content/uploads/2018/07/azar.pnghttps://timmermanreport.com/2018/07/alector-staying-private-for-now-pulls-in-133m-for-alzheimers-rd/sabahoney/2018-07-24T23:26:11+00:00https://timmermanreport.com/wp-content/uploads/2018/07/sabahoney.jpghttps://timmermanreport.com/2018/07/an-alzheimers-hope-fest-gsk-cozies-up-to-23andme-a-gilead-legend-steps-aside/andybiib/2018-07-26T23:40:01+00:00https://timmermanreport.com/wp-content/uploads/2018/07/andybiib.pnghttps://timmermanreport.com/2018/07/verana-backed-by-gv-brook-byers-grabs-30m-to-squeeze-meaning-out-of-emrs/mikikapoor/2018-07-30T21:02:24+00:00https://timmermanreport.com/wp-content/uploads/2018/07/mikikapoor.jpghttps://timmermanreport.com/readers-saying/kevin-james-hughes-biology-student/2018-08-02T18:34:02+00:00https://timmermanreport.com/wp-content/uploads/2018/08/Hughes-picture.jpeghttps://timmermanreport.com/about-luke-timmerman/080218-luketimmerman-pitch\_10/2018-08-06T19:10:28+00:00https://timmermanreport.com/wp-content/uploads/2018/08/080218-LukeTimmerman-pitch\_10.jpghttps://timmermanreport.com/2018/08/5am-nea-lead-50m-bet-on-akouos-crafting-gene-therapy-for-the-ear/amy-j-c-cuddy/2018-08-07T03:57:12+00:00https://timmermanreport.com/wp-content/uploads/2018/08/SimonsEJ\_Headshot.jpghttps://timmermanreport.com/2015/03/antibiotic-rd-getting-attention-whos/ankit\_mahadevia\_small\_b/2018-08-07T18:10:38+00:00https://timmermanreport.com/wp-content/uploads/2015/03/Ankit\_Mahadevia\_Small\_b-e1426115612339.jpghttps://timmermanreport.com/2018/08/alnylam-crosses-the-threshold-gileads-changing-of-the-guard-gene-therapy-financings-galore/gilmangiddy/2018-08-16T19:17:15+00:00https://timmermanreport.com/wp-content/uploads/2018/08/gilmangiddy.pnghttps://timmermanreport.com/2018/08/alnylam-crosses-the-threshold-gileads-changing-of-the-guard-gene-therapy-financings-galore/andyshort/2018-08-16T19:17:47+00:00https://timmermanreport.com/wp-content/uploads/2018/08/andyshort.pnghttps://timmermanreport.com/speaking-2/attachment/1/2018-08-18T04:57:16+00:00https://timmermanreport.com/wp-content/uploads/2018/08/1.jpghttps://timmermanreport.com/2018/08/time-and-money-what-are-they-worth-to-a-young-scientist/bluelinechart/2018-08-23T14:59:41+00:00https://timmermanreport.com/wp-content/uploads/2018/08/bluelinechart.jpghttps://timmermanreport.com/2018/08/time-and-money-what-are-they-worth-to-a-young-scientist/retirementchart/2018-08-23T15:00:23+00:00https://timmermanreport.com/wp-content/uploads/2018/08/retirementchart.jpghttps://timmermanreport.com/2018/09/fulcrum-gets-80m-to-test-small-molecules-against-rare-disorders-of-gene-expression/gould/2018-09-05T01:25:22+00:00https://timmermanreport.com/wp-content/uploads/2018/09/gould.jpghttps://timmermanreport.com/speaking-2/alnyeverest/2018-09-10T15:44:21+00:00https://timmermanreport.com/wp-content/uploads/2018/09/alnyeverest.jpghttps://timmermanreport.com/2018/09/jj-dumps-geron-roches-pd-l1-practice-changer-and-amarins-fish-oil-surprise/slavitt/2018-09-27T22:39:40+00:00https://timmermanreport.com/wp-content/uploads/2018/09/slavitt.pnghttps://timmermanreport.com/2018/09/jj-dumps-geron-roches-pd-l1-practice-changer-and-amarins-fish-oil-surprise/shaysarah/2018-09-27T22:40:11+00:00https://timmermanreport.com/wp-content/uploads/2018/09/shaysarah.pnghttps://timmermanreport.com/2018/09/jj-dumps-geron-roches-pd-l1-practice-changer-and-amarins-fish-oil-surprise/amarin/2018-09-27T22:40:49+00:00https://timmermanreport.com/wp-content/uploads/2018/09/amarin.pnghttps://timmermanreport.com/2018/09/jj-dumps-geron-roches-pd-l1-practice-changer-and-amarins-fish-oil-surprise/west1/2018-09-27T22:41:23+00:00https://timmermanreport.com/wp-content/uploads/2018/09/west1.pnghttps://timmermanreport.com/2018/09/jj-dumps-geron-roches-pd-l1-practice-changer-and-amarins-fish-oil-surprise/west2/2018-09-27T22:41:46+00:00https://timmermanreport.com/wp-content/uploads/2018/09/west2.pnghttps://timmermanreport.com/2018/10/nobel-highlights-and-lowlights-msk-fallout-continues-pfizer-ceo-stepping-down/garthwaite/2018-10-05T00:24:45+00:00https://timmermanreport.com/wp-content/uploads/2018/10/garthwaite.pnghttps://timmermanreport.com/2018/10/nobel-highlights-and-lowlights-msk-fallout-continues-pfizer-ceo-stepping-down/chentweet/2018-10-05T00:25:14+00:00https://timmermanreport.com/wp-content/uploads/2018/10/chentweet.pnghttps://timmermanreport.com/2018/10/nobel-highlights-and-lowlights-msk-fallout-continues-pfizer-ceo-stepping-down/boothpeople/2018-10-05T00:26:51+00:00https://timmermanreport.com/wp-content/uploads/2018/10/boothpeople.pnghttps://timmermanreport.com/2018/10/the-mit-biotech-group-alumni-where-are-they-now/jamesweis/2018-10-10T21:56:36+00:00https://timmermanreport.com/wp-content/uploads/2018/10/jamesweis.jpghttps://timmermanreport.com/2018/10/allogenes-megabucks-ipo-cvs-aetna-muscling-through-consumer-genetics-in-the-mainstream/generictrend/2018-10-11T22:54:48+00:00https://timmermanreport.com/wp-content/uploads/2018/10/generictrend.pnghttps://timmermanreport.com/2018/10/allogenes-megabucks-ipo-cvs-aetna-muscling-through-consumer-genetics-in-the-mainstream/andy1/2018-10-11T22:55:57+00:00https://timmermanreport.com/wp-content/uploads/2018/10/andy1.pnghttps://timmermanreport.com/2018/10/allogenes-megabucks-ipo-cvs-aetna-muscling-through-consumer-genetics-in-the-mainstream/andy2/2018-10-11T22:56:02+00:00https://timmermanreport.com/wp-content/uploads/2018/10/andy2.pnghttps://timmermanreport.com/2018/10/allogenes-megabucks-ipo-cvs-aetna-muscling-through-consumer-genetics-in-the-mainstream/andy3/2018-10-11T22:56:06+00:00https://timmermanreport.com/wp-content/uploads/2018/10/andy3.pnghttps://timmermanreport.com/2018/10/making-it-easy-to-share-biological-data-john-wilbanks-on-the-long-run-podcast/wilbanks/2018-10-16T16:55:13+00:00https://timmermanreport.com/wp-content/uploads/2018/10/wilbanks.pnghttps://timmermanreport.com/2018/10/making-it-easy-to-share-biological-data-john-wilbanks-on-the-long-run-podcast/wilbanks2018/2018-10-16T17:14:26+00:00https://timmermanreport.com/wp-content/uploads/2018/10/wilbanks2018.jpghttps://timmermanreport.com/2018/10/abbvie-plunks-down-100m-upfront-for-morphics-oral-integrin-inhibitors-for-fibrosis/praveen-crop-medium/2018-10-18T16:20:51+00:00https://timmermanreport.com/wp-content/uploads/2018/10/Praveen-crop-medium.jpghttps://timmermanreport.com/2018/10/amgens-price-cut-biogen-eisai-alzheimers-whiff-a-new-osteoarthritis-drug/diamond/2018-10-26T02:35:11+00:00https://timmermanreport.com/wp-content/uploads/2018/10/diamond.pnghttps://timmermanreport.com/2018/10/amgens-price-cut-biogen-eisai-alzheimers-whiff-a-new-osteoarthritis-drug/ban2401/2018-10-26T02:37:57+00:00https://timmermanreport.com/wp-content/uploads/2018/10/ban2401.jpghttps://timmermanreport.com/2018/10/amgens-price-cut-biogen-eisai-alzheimers-whiff-a-new-osteoarthritis-drug/ban2401slide/2018-10-26T02:37:59+00:00https://timmermanreport.com/wp-content/uploads/2018/10/ban2401slide.jpghttps://timmermanreport.com/2018/11/exploring-synthetic-lethal-cancer-drug-discovery-barbara-weber-on-the-long-run/weber/2018-10-26T18:58:31+00:00https://timmermanreport.com/wp-content/uploads/2018/10/weber.jpghttps://timmermanreport.com/2018/10/nine-vcs-who-matter-but-you-never-read-about/biotechshowcasebanner-2/2018-10-29T23:25:42+00:00https://timmermanreport.com/wp-content/uploads/2018/10/biotechshowcasebanner.jpghttps://timmermanreport.com/2018/10/nine-vcs-who-matter-but-you-never-read-about/bts\_banner\_1080x300/2018-10-29T23:28:52+00:00https://timmermanreport.com/wp-content/uploads/2018/10/BTS\_BANNER\_1080x300.jpghttps://timmermanreport.com/speaking-2/blueprinteveresttweet/2018-11-01T16:34:54+00:00https://timmermanreport.com/wp-content/uploads/2018/11/blueprinteveresttweet.jpghttps://timmermanreport.com/2018/11/illumina-takes-out-pacbio-abbvies-pre-emptive-price-cut-hhs-drug-pricing-go-to-guy-dies/clive/2018-11-01T23:33:22+00:00https://timmermanreport.com/wp-content/uploads/2018/11/clive.pnghttps://timmermanreport.com/2018/11/illumina-takes-out-pacbio-abbvies-pre-emptive-price-cut-hhs-drug-pricing-go-to-guy-dies/esperionchart/2018-11-01T23:34:28+00:00https://timmermanreport.com/wp-content/uploads/2018/11/esperionchart.pnghttps://timmermanreport.com/2018/11/sage-postpartum-depression-drug-passes-scrutiny-blavatniks-200m-beneficence-a-novartis-pricing-trial-balloon/pd1sales/2018-11-09T00:08:36+00:00https://timmermanreport.com/wp-content/uploads/2018/11/pd1sales.pnghttps://timmermanreport.com/2018/11/sage-postpartum-depression-drug-passes-scrutiny-blavatniks-200m-beneficence-a-novartis-pricing-trial-balloon/alnylamchart/2018-11-09T00:09:34+00:00https://timmermanreport.com/wp-content/uploads/2018/11/alnylamchart.pnghttps://timmermanreport.com/2017/03/biomatics-run-gates-vets-raises-200m-genomics-healthcare-startups/juliesunderland/2018-11-09T01:51:34+00:00https://timmermanreport.com/wp-content/uploads/2017/03/JulieSunderland.jpghttps://timmermanreport.com/2018/11/investing-at-the-nexus-of-biology-technology-julie-sunderland-of-biomatics-on-the-long-run/julie-sunderland-headshot/2018-11-09T01:56:15+00:00https://timmermanreport.com/wp-content/uploads/2018/11/Julie-Sunderland-Headshot.jpghttps://timmermanreport.com/2018/11/modernas-mega-ipo-plan-abbvie-nails-hcv-svb-takes-out-leerink/morrison/2018-11-16T00:38:49+00:00https://timmermanreport.com/wp-content/uploads/2018/11/morrison.pnghttps://timmermanreport.com/2018/11/modernas-mega-ipo-plan-abbvie-nails-hcv-svb-takes-out-leerink/tobacco/2018-11-16T00:40:17+00:00https://timmermanreport.com/wp-content/uploads/2018/11/tobacco.pnghttps://timmermanreport.com/2018/11/extending-human-healthspan-ned-david-of-unity-biotech-on-the-long-run/nathaniel-david-color/2018-11-19T22:57:04+00:00https://timmermanreport.com/wp-content/uploads/2018/11/Nathaniel-David-color.jpghttps://timmermanreport.com/team/alisonbheadshot/2018-12-03T13:49:55+00:00https://timmermanreport.com/wp-content/uploads/2018/12/AlisonBheadshot.pnghttps://timmermanreport.com/speaking-2/lolita/2018-12-05T20:35:31+00:00https://timmermanreport.com/wp-content/uploads/2018/12/lolita.jpghttps://timmermanreport.com/2018/12/23andme-the-burden-of-knowledge-and-the-real-value-of-money/kyletweet1/2018-12-06T23:59:22+00:00https://timmermanreport.com/wp-content/uploads/2018/12/kyletweet1.pnghttps://timmermanreport.com/2018/12/23andme-the-burden-of-knowledge-and-the-real-value-of-money/kyletweet2/2018-12-07T00:00:16+00:00https://timmermanreport.com/wp-content/uploads/2018/12/kyletweet2.pnghttps://timmermanreport.com/2018/12/osi-veterans-and-versant-ventures-unveil-startup-to-fight-allosteric-resistance-mutations-in-cancer/davidmepstein/2018-12-10T23:06:22+00:00https://timmermanreport.com/wp-content/uploads/2018/12/davidmepstein.pnghttps://timmermanreport.com/2018/12/osi-veterans-and-versant-ventures-unveil-startup-to-fight-allosteric-resistance-mutations-in-cancer/alexmayweg/2018-12-10T23:07:01+00:00https://timmermanreport.com/wp-content/uploads/2018/12/alexmayweg.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/kili\_700x330/2018-12-11T00:45:35+00:00https://timmermanreport.com/wp-content/uploads/2018/12/Kili\_700x330.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/bobmore-3/2018-12-11T00:49:03+00:00https://timmermanreport.com/wp-content/uploads/2018/12/bobmore.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/bob-more1/2018-12-11T01:03:18+00:00https://timmermanreport.com/wp-content/uploads/2018/12/Bob-More1.pnghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/garrym/2018-12-11T01:04:43+00:00https://timmermanreport.com/wp-content/uploads/2018/12/garrym.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/garrym-2/2018-12-12T00:06:21+00:00https://timmermanreport.com/wp-content/uploads/2018/12/garrym-1.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/geraldine-2/2018-12-12T00:06:26+00:00https://timmermanreport.com/wp-content/uploads/2018/12/geraldine-1.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/heidi\_hagen\_2018\_v2-1/2018-12-12T00:06:30+00:00https://timmermanreport.com/wp-content/uploads/2018/12/Heidi\_Hagen\_2018\_v2-1.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/kellyobrien2/2018-12-12T00:06:36+00:00https://timmermanreport.com/wp-content/uploads/2018/12/KellyOBrien2.pnghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/kirstenaxelsen/2018-12-12T00:06:41+00:00https://timmermanreport.com/wp-content/uploads/2018/12/KirstenAxelsen.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/lesleystolz/2018-12-12T00:06:48+00:00https://timmermanreport.com/wp-content/uploads/2018/12/LesleyStolz.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/nancymillerrich/2018-12-12T00:06:52+00:00https://timmermanreport.com/wp-content/uploads/2018/12/nancymillerrich.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/nina-kjellson/2018-12-12T00:07:00+00:00https://timmermanreport.com/wp-content/uploads/2018/12/Nina-Kjellson.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/simba-gill/2018-12-12T00:07:47+00:00https://timmermanreport.com/wp-content/uploads/2018/12/Simba-Gill.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/sanford-zweifach/2018-12-12T00:09:44+00:00https://timmermanreport.com/wp-content/uploads/2018/12/Sanford-Zweifach.jpghttps://timmermanreport.com/2018/12/first-everest-now-kilimanjaro-climb-with-me-and-a-great-biotech-team-to-fight-cancer/zbarry/2018-12-12T00:10:07+00:00https://timmermanreport.com/wp-content/uploads/2018/12/zbarry.jpghttps://timmermanreport.com/2018/12/google-money-at-work-in-biology-krishna-yeshwant-on-the-long-run/ppd-biotech-logo/2018-12-12T11:52:21+00:00https://timmermanreport.com/wp-content/uploads/2018/12/PPD-Biotech-Logo-e1544615709742.pnghttps://timmermanreport.com/2018/12/allens-125m-bet-on-immunology-gileads-new-ceo-insulin-price-gouging-scrutiny/bumol/2018-12-14T01:13:08+00:00https://timmermanreport.com/wp-content/uploads/2018/12/bumol.pnghttps://timmermanreport.com/2018/12/versant-ventures-reloads-with-700m-for-early-stage-biotech/bolzon/2018-12-16T18:41:12+00:00https://timmermanreport.com/wp-content/uploads/2018/12/bolzon.jpghttps://timmermanreport.com/2018/12/versant-ventures-reloads-with-700m-for-early-stage-biotech/woiwode/2018-12-16T18:41:57+00:00https://timmermanreport.com/wp-content/uploads/2018/12/woiwode.jpghttps://timmermanreport.com/2018/12/relay-therapeutics-hauls-in-400m-to-push-frontier-in-computational-drug-discovery/sanjiv-patel/2018-12-20T01:24:19+00:00https://timmermanreport.com/wp-content/uploads/2018/12/sanjiv-patel.jpghttps://timmermanreport.com/2018/12/relay-therapeutics-hauls-in-400m-to-push-frontier-in-computational-drug-discovery/borisy/2018-12-20T01:25:42+00:00https://timmermanreport.com/wp-content/uploads/2018/12/borisy.jpghttps://timmermanreport.com/readers-saying/oleg1/2018-12-20T01:26:23+00:00https://timmermanreport.com/wp-content/uploads/2015/01/oleg1.pnghttps://timmermanreport.com/2019/01/from-merck-fast-track-to-computer-chem-frontier-karen-akinsanya-on-the-long-run/karen\_akinsanya\_headshot/2019-01-02T16:54:51+00:00https://timmermanreport.com/wp-content/uploads/2019/01/karen\_akinsanya\_headshot.pnghttps://timmermanreport.com/2019/01/bms-celgene-megamerger-verily-pockets-1b-and-abbvies-wager-on-cd39/datweet/2019-01-04T01:38:02+00:00https://timmermanreport.com/wp-content/uploads/2019/01/datweet.pnghttps://timmermanreport.com/2019/01/bms-celgene-megamerger-verily-pockets-1b-and-abbvies-wager-on-cd39/datweet2/2019-01-04T01:38:07+00:00https://timmermanreport.com/wp-content/uploads/2019/01/datweet2.pnghttps://timmermanreport.com/2019/01/bms-celgene-megamerger-verily-pockets-1b-and-abbvies-wager-on-cd39/datweet3/2019-01-04T01:38:13+00:00https://timmermanreport.com/wp-content/uploads/2019/01/datweet3.pnghttps://timmermanreport.com/2019/01/schrodinger-backed-by-gates-and-wuxi-grabs-85m-for-computational-drug-discovery-qa-with-ceo-ramy-farid/farid\_140x140/2019-01-05T01:51:41+00:00https://timmermanreport.com/wp-content/uploads/2019/01/farid\_140x140.pnghttps://timmermanreport.com/2019/01/lilly-buys-loxo-baselga-resurfaces-and-bluebirds-gene-therapy-payment-plan/azartweet/2019-01-11T01:01:24+00:00https://timmermanreport.com/wp-content/uploads/2019/01/azartweet.pnghttps://timmermanreport.com/2019/01/lilly-buys-loxo-baselga-resurfaces-and-bluebirds-gene-therapy-payment-plan/andysurvival/2019-01-11T01:02:38+00:00https://timmermanreport.com/wp-content/uploads/2019/01/andysurvival.pnghttps://timmermanreport.com/2019/01/house-dems-hunt-pharma-big-game-shutdown-woes-jpm-reflections/steensma/2019-01-17T23:17:05+00:00https://timmermanreport.com/wp-content/uploads/2019/01/steensma.pnghttps://timmermanreport.com/2019/01/house-dems-hunt-pharma-big-game-shutdown-woes-jpm-reflections/steensma2/2019-01-17T23:17:55+00:00https://timmermanreport.com/wp-content/uploads/2019/01/steensma2.pnghttps://timmermanreport.com/2019/01/house-dems-hunt-pharma-big-game-shutdown-woes-jpm-reflections/steensma3/2019-01-17T23:19:21+00:00https://timmermanreport.com/wp-content/uploads/2019/01/steensma3.pnghttps://timmermanreport.com/2019/01/house-dems-hunt-pharma-big-game-shutdown-woes-jpm-reflections/steensma4/2019-01-17T23:19:50+00:00https://timmermanreport.com/wp-content/uploads/2019/01/steensma4.pnghttps://timmermanreport.com/2019/01/genentech-ceo-in-editas-ceo-out-the-shutdown-ipo/kaplan/2019-01-25T00:19:15+00:00https://timmermanreport.com/wp-content/uploads/2019/01/kaplan.pnghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/kilimanjaro-header/2019-01-29T16:32:40+00:00https://timmermanreport.com/wp-content/uploads/2019/01/Kilimanjaro-header.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/kilimanjaro-header-2/2019-01-29T16:40:44+00:00https://timmermanreport.com/wp-content/uploads/2019/01/Kilimanjaro-header-1.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/new-climb-logo-black/2019-01-29T17:38:49+00:00https://timmermanreport.com/wp-content/uploads/2019/01/NEW-CLIMB-LOGO-black.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/fmilogo/2019-01-29T17:38:51+00:00https://timmermanreport.com/wp-content/uploads/2019/01/fmilogo.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/veracyte\_rgb\_lrg\_h/2019-01-29T17:38:53+00:00https://timmermanreport.com/wp-content/uploads/2019/01/Veracyte\_RGB\_LRG\_H.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/jji-jlabs\_stacked\_rgb\_300dpi/2019-01-30T14:52:16+00:00https://timmermanreport.com/wp-content/uploads/2019/01/JJI-JLabs\_Stacked\_RGB\_300dpi.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/biocom\_logo\_horizontal/2019-01-30T14:52:19+00:00https://timmermanreport.com/wp-content/uploads/2019/01/Biocom\_Logo\_Horizontal-e1548959287777.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/alexion-logo/2019-01-31T15:53:17+00:00https://timmermanreport.com/wp-content/uploads/2019/01/alexion-logo-e1548950122983.pnghttps://timmermanreport.com/2019/02/get-tickets-now-the-cancer-summit-series-is-coming-to-boston-sf-seattle/registration\_form\_header\_830x224/2019-02-05T18:24:28+00:00https://timmermanreport.com/wp-content/uploads/2019/02/Registration\_Form\_Header\_830x224-e1550689212814.jpghttps://timmermanreport.com/2019/02/azar-angles-for-a-deal-pharma-can-live-with-macrogenics-big-break-sanofi-scraps-38-rd-programs/reedaruba/2019-02-08T04:02:17+00:00https://timmermanreport.com/wp-content/uploads/2019/02/ReedAruba.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/madryn\_logo-lockup\_final/2019-02-13T18:48:30+00:00https://timmermanreport.com/wp-content/uploads/2019/02/Madryn\_logo-lockup\_final-e1550083736528.jpghttps://timmermanreport.com/2019/02/the-pcsk9-price-cut-jj-depression-drug-passes-test-gileads-nash-strikeout/jessica/2019-02-15T00:32:04+00:00https://timmermanreport.com/wp-content/uploads/2019/02/jessica.pnghttps://timmermanreport.com/2019/02/the-boston-cancer-summit-and-sf-cancer-summit-see-the-agenda-get-your-tickets/registration\_form\_header\_830x224-2/2019-02-20T19:01:30+00:00https://timmermanreport.com/wp-content/uploads/2019/02/Registration\_Form\_Header\_830x224-1-e1550689310437.jpghttps://timmermanreport.com/2019/02/third-rock-arch-join-forces-lead-191m-bet-on-maze-and-gene-modifiers/chomcy/2019-02-28T00:24:30+00:00https://timmermanreport.com/wp-content/uploads/2019/02/chomcy.jpghttps://timmermanreport.com/2019/03/pharma-dodges-senate-bullet-roche-pays-4-8b-for-spark-bms-celgene-deal-wobbles/attachment/2281/2019-03-01T00:56:29+00:00https://timmermanreport.com/wp-content/uploads/2019/02/2281.pnghttps://timmermanreport.com/2019/03/pharma-dodges-senate-bullet-roche-pays-4-8b-for-spark-bms-celgene-deal-wobbles/attachment/2282/2019-03-01T00:56:59+00:00https://timmermanreport.com/wp-content/uploads/2019/02/2282.pnghttps://timmermanreport.com/2019/03/pharma-dodges-senate-bullet-roche-pays-4-8b-for-spark-bms-celgene-deal-wobbles/attachment/2283/2019-03-01T00:57:25+00:00https://timmermanreport.com/wp-content/uploads/2019/02/2283.pnghttps://timmermanreport.com/2019/03/pharma-dodges-senate-bullet-roche-pays-4-8b-for-spark-bms-celgene-deal-wobbles/attachment/2284/2019-03-01T00:57:55+00:00https://timmermanreport.com/wp-content/uploads/2019/02/2284.pnghttps://timmermanreport.com/2019/03/beam-therapeutics-pushing-the-edges-in-base-editing-raises-135m/john-evans/2019-03-05T22:53:22+00:00https://timmermanreport.com/wp-content/uploads/2019/03/john-evans.jpghttps://timmermanreport.com/events/collinsplenary/2019-03-12T18:44:35+00:00https://timmermanreport.com/wp-content/uploads/2014/12/collinsplenary-e1552416224931.jpghttps://timmermanreport.com/2019/03/seeing-lots-of-single-cells-up-close-serge-saxonov-of-10x-genomics-on-the-long-run/serge-saxonov-1/2019-03-12T21:48:33+00:00https://timmermanreport.com/wp-content/uploads/2019/03/serge-saxonov-1.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/servier-bleu/2019-03-13T16:06:49+00:00https://timmermanreport.com/wp-content/uploads/2019/03/servier-bleu.pnghttps://timmermanreport.com/2019/03/ai-drug-discovery-starts-to-come-of-age-as-it-aims-for-the-clinic/aheifets/2019-03-13T21:38:04+00:00https://timmermanreport.com/wp-content/uploads/2019/03/aheifets.jpghttps://timmermanreport.com/2019/03/sharpless-in-the-saddle-nih-threatened-again-pbms-prep-for-senate-scrutiny/front1/2019-03-15T01:06:02+00:00https://timmermanreport.com/wp-content/uploads/2019/03/front1.pnghttps://timmermanreport.com/2019/03/sharpless-in-the-saddle-nih-threatened-again-pbms-prep-for-senate-scrutiny/front2/2019-03-15T01:06:35+00:00https://timmermanreport.com/wp-content/uploads/2019/03/front2.pnghttps://timmermanreport.com/2019/03/sharpless-in-the-saddle-nih-threatened-again-pbms-prep-for-senate-scrutiny/front3/2019-03-15T01:07:55+00:00https://timmermanreport.com/wp-content/uploads/2019/03/front3.pnghttps://timmermanreport.com/2019/03/ai-drug-discovery-starts-to-come-of-age-as-it-aims-for-the-clinic/barzilay/2019-03-19T02:19:31+00:00https://timmermanreport.com/wp-content/uploads/2019/03/barzilay.jpghttps://timmermanreport.com/2019/03/researchers-look-to-the-immune-system-after-relentless-alzheimers-failures/caseylynch/2019-03-22T21:14:07+00:00https://timmermanreport.com/wp-content/uploads/2019/03/caseylynch.jpghttps://timmermanreport.com/2019/03/life-of-a-scientific-entrepreneur-bob-langer-of-mit-on-the-long-run/langer\_photo\_courtesy/2019-03-27T02:24:56+00:00https://timmermanreport.com/wp-content/uploads/2019/03/Langer\_Photo\_courtesy.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/exactsciencesnew/2019-03-28T22:42:10+00:00https://timmermanreport.com/wp-content/uploads/2019/03/exactsciencesNew.jpghttps://timmermanreport.com/2019/03/thermo-bets-on-viral-vector-manufacturing-precision-genfits-ipos-not-much-else/bobmoretweet/2019-03-28T23:10:57+00:00https://timmermanreport.com/wp-content/uploads/2019/03/bobmoretweet.pnghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/5am/2019-03-30T22:29:02+00:00https://timmermanreport.com/wp-content/uploads/2019/03/5am-e1553984979493.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/pfizer/2019-03-30T22:31:12+00:00https://timmermanreport.com/wp-content/uploads/2019/03/pfizer-e1553985091158.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/sofinnova/2019-03-30T22:32:11+00:00https://timmermanreport.com/wp-content/uploads/2019/03/sofinnova-e1553985147651.jpghttps://timmermanreport.com/2019/04/foundation-flatiron-cross-the-genotype-phenotype-chasm-show-clinical-cancer-genome-database-at-work/fmi\_gauravs\_portrait\_01v2\_dotcom/2019-04-09T00:17:38+00:00https://timmermanreport.com/wp-content/uploads/2019/04/FMI\_GauravS\_portrait\_01v2\_dotcom.jpghttps://timmermanreport.com/2019/04/the-road-less-traveled-in-glycoscience-carolyn-bertozzi-on-the-long-run/bertozzi/2019-04-09T19:19:04+00:00https://timmermanreport.com/wp-content/uploads/2019/04/bertozzi.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/atumbio/2019-04-12T12:46:34+00:00https://timmermanreport.com/wp-content/uploads/2019/04/atumbio.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/blueprint/2019-04-12T12:47:15+00:00https://timmermanreport.com/wp-content/uploads/2019/04/blueprint-e1555102354969.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/atumgray/2019-04-12T12:48:38+00:00https://timmermanreport.com/wp-content/uploads/2019/04/atumgray.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/atumwhite/2019-04-12T12:49:47+00:00https://timmermanreport.com/wp-content/uploads/2019/04/atumwhite.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/nektar/2019-04-12T20:49:27+00:00https://timmermanreport.com/wp-content/uploads/2019/04/nektar-e1555102203236.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/zymeworks/2019-04-12T20:51:30+00:00https://timmermanreport.com/wp-content/uploads/2019/04/zymeworks-e1555102318438.jpghttps://timmermanreport.com/2019/04/mit-project-alpha-aiming-to-give-early-biopharma-investors-better-odds/andrewlo/2019-04-13T15:53:10+00:00https://timmermanreport.com/wp-content/uploads/2019/04/andrewlo.jpghttps://timmermanreport.com/2019/04/life-after-twitter/dshaywitz/2019-04-15T12:35:06+00:00https://timmermanreport.com/wp-content/uploads/2015/01/dshaywitz.jpghttps://timmermanreport.com/2019/04/3-lessons-for-success-in-research-reflections-from-aacr-2019/comics/2019-04-17T21:36:13+00:00https://timmermanreport.com/wp-content/uploads/2019/04/comics.pnghttps://timmermanreport.com/2019/04/3-lessons-for-success-in-research-reflections-from-aacr-2019/phdcomics/2019-04-17T21:39:12+00:00https://timmermanreport.com/wp-content/uploads/2019/04/phdcomics.jpghttps://timmermanreport.com/2019/04/the-gut-microbiome-modifies-immuno-oncology-response-suggesting-ways-to-accelerate-activity/chris\_s\_final\_web/2019-04-17T22:07:39+00:00https://timmermanreport.com/wp-content/uploads/2019/04/Chris\_S\_Final\_web.jpghttps://timmermanreport.com/2019/04/the-gut-microbiome-modifies-immuno-oncology-response-suggesting-ways-to-accelerate-activity/bernat/2019-04-17T22:09:01+00:00https://timmermanreport.com/wp-content/uploads/2019/04/bernat.jpghttps://timmermanreport.com/kilimanjaro-climb-to-fight-cancer/mirati/2019-04-22T21:57:48+00:00https://timmermanreport.com/wp-content/uploads/2019/04/mirati-e1555970255190.jpg